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ABSTRACT 
The purpose of this study was to examine the acute effects of oral creatine 
hydrochloride (CrHCl) supplementation on three repeated bouts of bench press and 
vertical jumping exercises and body composition measures (body weight (BW), fat-free 
mass (FFM) and fat mass (FM)). Methods: Fifteen resistance trained males completed 3 
sets of the barbell bench press (70% 1RM) and 3 sets of the repeated counter-movement 
vertical jump (CMJ; 85% maximal CMJ height), with 2 min rest between sets, before and 
after a 7 d CrHCl intervention (4 g·day-1). A two-factor repeated measures ANOVA was 
used to determine significant main effects (time and set) with post-hoc Bonferroni 
analysis and interaction effects (time x set) for bench press and CMJ performances from 
pre- to post-intervention. A one-factor repeated measures ANOVA was used to assess 
pre- to post-intervention differences in body composition. Results: Significant main and 
interaction effects for time and set were found in the bench press from pre- to post-
intervention (p < 0.005, for all) with Bonferroni analysis indicating increased 
performance on later sets (eg, Set 3 > Set 2 > Set 1, p < 0.005). Significant main effects 
for time and set were found in the CMJ test from pre- to post-intervention (p < 0.005) but 
no interaction effect was found (p > 0.05). Post hoc analysis indicated increased 
performance on later sets. BW was the only body measure to reach significance (p < 
0.005). Conclusion: Supplementation with 4 g of CrHCl for 7 d in healthy, resistance 
trained men significantly increased the number of repetitions performed during 
intermittent bouts of submaximal bench press and CMJ exercises and body weight. 
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CHAPTER ONE: INTRODUCTION 
Physical Fitness and Physical Activity  
Physical fitness (PF) is a set of skill- or health-related attributes which may be 
evaluated through a variety of physical tests (eg, the mile-run test).1 One’s level of PF is 
imperative to their health and overall quality of life, and according to the American 
College of Sports Medicine (ACSM), embodies five fundamental components: 1) 
cardiovascular endurance, 2) muscular endurance, 3) flexibility and mobility, 4) muscular 
strength, and 5) body-composition.2,3 A sixth component suggested by Clarke is muscular 
power.4 Physical activity (PA) is movement of the body produced by action of the 
muscle, causing an increase in energy expenditure and is critical to improving and 
maintaining PF.1 PA creates the greatest demand for the transfer of energy in the body.1 
There are three distinct systems utilized to provide the energy, and the intensity and 
duration of a given physical task determines which predominates: 1) immediate-term 
adenosine triphosphate-phosphocreatine (ATP-PCr) system, 2) short-term glycolytic 
system, and 3) long-term aerobic system.5  
Energy Transfer During PA 
ATP is the body’s energy currency because this energy-rich nucleotide-molecule 
provides power for all cells’ energy-driven processes.6 Energy is released from ATP 
when it loses an inorganic phosphate (Pi) molecule to form adenosine diphosphate 
(ADP).7 ATP is restored by adding back the Pi to ADP.
8 There is limited ATP storage to 
increase the sensitivity and responsiveness of energy supply.8 PCr is stored as the energy 
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reservoir because this high-energy, intracellular phosphate-compound undergoes 
anaerobic (without oxygen (O2)) splitting of one of its Pi molecules for the rapid, short-
term re-synthesis of ATP.9 Both molecules maintain similar characteristics as a vast 
amount of free-energy (~7.3 kcal·mol-1) gets released when the Pi is released in a 
reversible reaction.10 Creatine kinase (CK, ~5% on the outer membrane of the 
mitochondria, ~4% on the sarcomere, ~90% in the cytosol) catalyzes the near-equilibrium 
equation: PCr + ADP + hydrogen (H+) ↔ Cr + ATP.10-12 Because PCr’s CK-driven 
hydrolysis has a much greater free energy than that of ATP, it rapidly drives the 
phosphorylation of ADP to resynthesize ATP.11,13 During periods of all-out muscle 
contractions and a high demand for ATP, this process is driven to the right which reduces 
PCr concentration while simultaneously increasing free Cr (FCr) and Pi ion 
concentrations and maintaining ATP concentration nearly unchanged.10,14 The process is 
reversed during recovery periods, as the free Cr and one Pi ions bind, favoring PCr 
synthesis.10 This energy system is engaged at the initiation of PA and in all-out PA as 
skeletal muscle has the unique ability to rapidly increase its rate of energy consumption. 
Under conditions where explosive, maximal contractions are required, the millisecond 
increase in the turnover of energy can be up to 300-fold from resting to the fully-
activated state.10,15,16 Consequently, the availability of contributing sources to the ATP-
PCr energy system within the muscle cells, such as Cr concentration, become crucial as 
short-duration, near-maximal exercise proceeds and muscular fatigue begins to set in, 
requiring further ATP resynthesis.17 Cr serves as a buffer to H+ and ADP which 
accumulate in the muscle fibers as a product of ATP hydrolysis, lowering the pH and 
decreasing muscular performance.18 Given that skeletal muscle cells, especially type II, 
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fast-twitch fibers, store approximately four-to six-times more PCr than ATP, it is 
advantageous to maintain high levels of intramuscular total Cr (TCr) content (FCr + PCr) 
for those who participate in short duration, maximal-effort exercise lasting 5-8 s, and up 
to 30 s for near-maximal PA.10,14,16,19-21 Because of the training protocols used, this 
applies too, to those who resistance train with the intent to increase muscular strength, 
muscular power, and improve fat-free mass (FFM; total amount of lean (non-fat) parts of 
one’s body).22 However, the ability to resynthesize ATP via PCr hydrolysis declines 
approximately three-times faster than that of glycolysis (carbohydrate (CHO) 
catabolism).23,24 Thus, a greater quantity of Cr and PCr in skeletal muscle may translate 
to a greater quantity of ATP resynthesis via PCr hydrolysis and allow for more energy to 
be derived from high-energy phosphates before shifting to glycolytic pathways.25 
Creatine 
Cr is an organic, nitrogen-containing compound that is derived from the 
nonessential amino acids arginine, glycine, and methionine, that is, the body can 
manufacture creatine.26 Primarily the liver, but also the kidneys and pancreas, synthesize 
approximately 1 g·day-1 of Cr, in addition to the approximately 1 g·day-1 obtained through 
the typical, non-vegetarian diet.26-28 95%-98% of the body’s 120-140 g of Cr is found in 
skeletal muscle, approximately 40% as FCr and the remaining 60% combined with Pi to 
form PCr.12,29 FCr undergoes nonenzymatic cyclization and approximately 1.6% of this 
TCr pool gets degraded to creatinine (Cn; sole byproduct of Cr metabolism) per day, and 
undergoes renal excretion.12,26,28-33 Therefore, a sedentary, 70 kg man who maintains a 
120 g TCr pool, loses approximately 2 g Cr·day-1 and TCr levels are maintained. 
However, Cn production and loss increases with PA levels.12,30 As the intensity and time 
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of PA increases, individuals who wish to maintain maximal effort may seek alternative 
methods of maximizing intramuscular TCr levels.12,30 Thus, the exogenous 
supplementation of Cr is a common practice among those who resistance train as a means 
of maintaining elevated intramuscular TCr levels and enhancing total work output.12 
Creatine as a Supplement 
The average daily intake of Cr is approximately 1 g·day-1 (0.2 kg of uncooked 
meat contains approximately 1 g of Cr) and may be much lower for vegetarians who may 
consume minimal amounts of animal-food sources.12,29,34-37 Cr content in meat (eg, beef 
and lamb) has been shown to decrease with cooking (90 min, 70 C), as evidenced by an 
increase in Cn levels.38 Thus, exogenous ingestion of Cr through dietary supplements 
(commercially available products consumed in addition to one’s usual diet) has long been 
practiced as an effective means for maintaining elevated intramuscular TCr levels.12,39 
When ingested, Cr progresses through the intestinal mucosa of the digestive tract, 
arguably unaltered, where it then gets absorbed into the blood stream and ultimately, 
stored in skeletal muscle for the maintenance of energy homeostasis.40 Muscle TCr stores 
may be increased via supplementation and reach their typical limits (150-155 mmol·kg-1 
(dry muscle; DM)), resulting in excess Cr not being taken up by the muscle and voided in 
the urine.40  
CrH2O Supplementation 
One of the most researched and consumed form of Cr supplements is Cr 
monohydrate (CrH2O).
41 Harris et al. were among the first to demonstrate that oral 
supplementation of 20-30 g·day-1 of CrH2O for several days could increase intramuscular 
TCr content between 30-50%, with approximately 30% of the Cr being retained by the 
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muscle in the first 2 d.42 The majority of studies that supplemented Cr at the 
recommended doses (eg, 4-5 g·day-1 , 10 d or 2-4 g·day-1, 30 d) reported performance 
enhancement on exercises where energy transfer is mostly from the phosphagen energy 
system, and the brief, between-bout rest periods are sufficient to restore intramuscular 
PCr in participants.  
All-out PA with CrH2O supplementation is enhanced because the elevation in 
intramuscular TCr content allows for a prolonged use of PCr and replenishment of ATP, 
especially during intermittent exercise.23,43-48 Thus, better performances on maximal-
effort tasks that go beyond relying solely on readily available ATP (eg, 1RM bench 
press) and rely on PCr hydrolysis to maintain maximal exertion.44-46 Moreover, because 
elevated intramuscular PCr may promote buffering of H+ ions and ADP during maximal 
muscular contractions and reduce neuromuscular fatigue, this may allow for an increase 
in the number of muscular contractions possible during a given short-bout high intensity 
activity, such as resistance training.18,19,25,26,49-51 This ability for prolonged muscle 
contractions may ultimately lead to hypertrophy of the targeted skeletal muscle tissue and 
increased lean body mass due to the increased resistance training volume and elevated 
muscle protein synthesis.23,47,52-55 Phillips and colleagues propose that because one of the 
most crucial stimuli for elevating skeletal muscle protein synthesis is muscle contraction, 
the greater number of contractions in a given training period may promote an elevated 
cumulative stimulus for protein synthesis and greater net muscle protein retention 
(skeletal muscle hypertrophy).52,56 
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Body Mass and Lean Mass Effects of CrH2O Supplementation 
Though most of the literature has found acute CrH2O interventions to positively 
influence body composition, few studies have found no or insignificant (~0.5 kg) changes 
in FFM (healthy, older males) after 10 d of supplementing with CrH2O (20 g·day
-1). 
Further, men tend to accrue greater changes than women, likely due to their larger muscle 
mass.26,57-59 Independent of changes in hormonal (cortisol or testosterone) concentrations, 
CrH2O supplementation often results in increased body mass, ranging from 0.5-3 kg in 
periods between 1-3 wk.23,26,30,60-63 It remains unclear, however, the mechanism(s) by 
which this occurs, whether it be elevated intramuscular water retention, the direct 
anabolic effect of Cr on skeletal muscle tissue synthesis, or other indirect factors.64 It was 
further found that CrH2O supplementation, in addition to the resistance training protocol, 
promoted greater cross-sectional area of the muscle fibers: type I: 35% vs 11%; type IIA: 
36% vs 15%; type IIAB: 35% vs 6%, with vs. without supplementation, respectively.61 
Participants in this study who were given the CrH2O treatment were able to train at 
higher volumes during wk 5-8, which suggests that increased quality in training sessions 
led to more favorable adaptations in their FFM and overall muscle morphologies.61  
Issues and Non-Severe Adverse Effects with CrH2O Supplementation 
It is important to note that chronic Cr supplementation lasting up to 4 y has not 
yielded any serious adverse health effects and up to 5 y had no effect on renal functioning 
among healthy athletes.65 Moreover, some anecdotes report hypertensive effects upon 
supplementing with Cr, though acute (5 d, 20 g·day-1 ) and longer-duration (6 wk, 20 
g·day-1 (3 d), 10 g·day-1 maintenance) interventions have been shown to have no effects 
on blood pressure (systolic, diastolic, and mean).66,67  
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More commonly anecdotally reported non-severe adverse effects accompany 
CrH2O supplementation, such as subcutaneous water retention, gastrointestinal distress, 
nausea, and vomiting. These may be attributed to factors, such as co-ingestion with other 
nutrients (eg, large doses of CHO), timing of ingestion (in the periworkout period), or a 
lack of ability for all of it to pass through the intestinal epithelial cells and make it into 
circulation.26,68,69 CrH2O supplementation often accompanies weight gain, not just in 
FFM, however, but also by water retention in the muscle fiber and subcutaneous 
space.70,71 Moreover, supplementing with CrH2O has caused gastrointestinal distress, 
with reports of abdominal aches and cramps.26,72,73 There is a possible correlation 
between mega-doses of CrH2O in one serving, otherwise known as a “loading phase,” 
where 10 g or more is ingested, and increased risk of diarrhea.74,75 This effect is likely 
due to the fact that CrH2O is poorly soluble in liquid and consequently, poorly absorbed 
by the intestines where the substance then sits and draws water in to the intestinal 
tract.26,69,72,74-76 Another study showed using an in-vitro model that a range of only 0.2-
3% of ingested CrH2O was able to pass through the intestinal cells for upwards of a 90 
min time period with the remainder being excreted by the body.77  
A potential enhancement of CrH2O uptake is that of insulin augmenting Cr uptake 
by the skeletal muscles.25,40,64,78-81 Only approximately 50% of participants who 
supplemented with CrH2O alone, positively responded (significantly enhanced their 
intramuscular TCr), but 100% positively responded with the presence of a large bolus of 
simple carbohydrates (CHO), such as dextrose.42,81,82 It takes approximately 95 g of 
simple CHO to provide a sufficient insulin spike to positively affect the intramuscular 
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uptake of TCr upon supplementation with CrH2O.
40,78-80 This insulin effect on Cr 
retention is likely due to insulin-stimulating, Na+-dependent, muscle-Cr transport.26,40,83,84  
Cr retention in the body after supplementing can be tested via urinalysis, as Cn 
undergoes excretion by the kidneys, and increases gradually after the first few days as 
supplementation continues.12,26,28-33,85 Chanutin et al. reported that approximately 100% 
of ingested Cr passes through the intestines and makes it into the bloodstream, though 
most of the body’s Cr retention takes place within the first couple of d and approximately 
90% of ingested Cr is excreted thereafter, with continued supplementation.85 Thus, as 
myocytes no longer maintain the capacity to extract circulating Cr from the blood after 
the first few days of supplementation (10-20 g·day-1), bodily retention will decline, and 
the excess will be excreted as Cr in the urine.85 However, elevated TCr levels may be 
maintained if one continues to supplement with Cr while following a resistance training 
program, as trained skeletal muscle tissue better takes up circulating Cr, especially as 
intramuscular Cr levels decrease from training and natural metabolic processes.42  
Given the popularity of this dietary supplement and these potential adverse effects 
associated with it, manufacturers have attempted to produce different forms of Cr with 
the same performance benefits, minus the ill-effects of the monohydrate form. Cr 
hydrochloride (CrHCl) was introduced to the market around 2009 as new form of Cr and 
is claimed to reduce the adverse effects of CrH2O while providing the same performance 
and FFM benefits as the CrH2O form.
76 
Creatine Hydrochloride 
CrHCl is created using CrH2O and acetyl chloride (CH3COCl) as reactants with 
ethanol (C2H6O) as the solvent, which then produces a granular precipitate consisting of 
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CrHCl salt, both in a high purity and yield.76 CrHCl products are typically much more 
expensive than CrH2O products (eg, NutraBio Creatine HCl, 135g, $29.99: NutraBio 
Creatine Monohydrate Powder, 500g, $14.99; NutraBio Labs, Middlesex, NJ).86  
Enhanced Solubility and Intestinal-Uptake of CrHCl  
CrHCl was created as a form of Cr that yields higher aqueous solubility with the 
intention of being better mixed in liquid and better absorbed and retained with the same 
intended applications as CrH2O.
76 The CrHCl patent reported the aqueous solubility of 
CrHCl to be in excess of approximately 150 mg·mL-1 , while that of CrH2O and Cr citrate 
salt was only approximately 10-15 mg·mL-1.76 Subsequent research has confirmed their 
claims, finding CrHCl to be 38-times more soluble in solution than its CrH2O 
counterpart.87 Following, Gufford and colleagues reported that when Cr ethyl ester was 
placed in a highly acidic state (HCl), with the pH stabilized at pH 1.0, the amount of Cr 
absorbed by the intestines consequently increased 60%, due to the enhanced solubility 
and greater permeability characteristics under these acidic conditions, in comparison to 
CrH2O, which is more basic in nature.
69 Gufford et al. propose that because the added 
HCl group is highly stable at the pH level of the gastrointestinal tract, its greater 
permeability and absorption are superior to that of Cr, alone.69 This contradicts the 
aforesaid findings in the Chanutin et al. study, as it was found that nearly all of the Cr 
ingested passed through the intestines and made it into circulation.85 Nevertheless, the 
implication is that CrHCl can be supplemented at a much smaller dose than CrH2O, while 
still producing similar performance benefits with a reduced potential for the reported side 
effects. Therefore, with greater solubility in liquid, more efficient absorption by the 
intestines, and a smaller required dose than CrH2O, CrHCl may minimize the stomach 
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and water retention issues reported by those who supplement with CrH2O. However, a 
study examining the body’s retention of Cr upon supplementing with CrHCl would be 
needed to tell whether these retention-effects are truly prevalent; currently, no such 
literature exists.  
Need for the study 
The study at hand will be among the first to investigate the acute resistance 
training responses after 7 d of supplementing with CrHCl. This study will bring value to 
the literature as it will add to the sparse literature pertaining to CrHCl as a dietary 
supplement and will provide data that can be compared with previous findings in regards 
to CrH2O’s ability to acutely affect submaximal, intermittent exercise 
performances.23,40,42,78 These findings will allow for researchers and consumers to decide 
which form of Cr is superior for consumption based on dosing requirements and 
performance benefits.  
Hypotheses 
It was hypothesized that: 
1) 4 g of CrHCl·day-1 for 7 d will significantly increase repetitions completed on 
three sets of the repeated barbell bench press and CMJ exercises at 70% of 
participants’ 1RMs.  
2) 4 g of CrHCl·day-1 for 7 d will significantly increase BW, FFM and decrease FM.  
Delimitations 
The study at hand will require participants to be currently resistance trained 
(minimum of 3 d·wk-1) with a minimum of 1 y experience. Moreover, participants will be 
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between the ages of 18 and 34 y, will not use anabolic steroids, be vegans or vegetarian, 
and/or must cease the use of their current nutritional supplement regimens.  
Limitations 
Limitations of the current study include untested participants who are: 
 Untrained and low-trained. 
 Youth, not 18 y of age and adults and elderly, greater than 34 y of age. 
 Anabolic steroid users. 
 Vegans and vegetarians. 
 Diabetics. 
 Unwilling to stop taking dietary supplements. 
12 
 
CHAPTER TWO: LITERATURE REVIEW 
Selection Criteria 
Selection criteria for this review gave preference to studies investigating CrH2O’s 
retention, and training studies pertaining to both CrHCl and CrH2O whose participants 
were: 1) non-vegetarian or vegan, 2) male and female, 3) currently well trained 
(minimum 1 y of current and consistent resistance training experience), 4) non-steroid 
users, 5) not taking any other supplements at the time of the respective study, and 6) non-
diabetics. Studies investigating the retention of TCr after supplementing with CrH2O will 
be restricted to 1992, and beyond, as this was the year of the seminal study by Harris et 
al. that first investigated this.42 Any study examining CrHCl supplementation will be 
restricted to 2009 and beyond, as this was when it was first brought to the market for 
commercial use.42,76 No such literature exists relative to TCr pool enhancement and 
retention upon supplementing with CrHCl and thus, will be disregarded from this review. 
Studies detailing the intramuscular ATP-PCr energy system and/or skeletal muscle 
structure and function will have no date restrictions.  
Review Format 
The review starts with a brief section detailing the ATP-PCr energy system. 
Following is a section reviewing CrH2O retention studies. Subsequent is a section 
reviewing the ergogenic benefits of Cr supplementation across different forms of PA, 
followed by a section reviewing anecdotal adverse effects associated with CrH2O 
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supplementation. Following will be a section on CrHCl and any literature available 
pertaining to it, which currently is very limited. 
Key Terms and Phrases 
Key terms and phrases used in this search were “ATP-PCr,” “anaerobic energy,” 
“anaerobic metabolism,” “creatine,” “creatine monohydrate,” “creatine hydrochloride,” 
“creatine HCl,” “creatine retention, “creatine carbohydrate,” “creatine insulin,” “creatine 
solubility,” “muscle fiber,” and “type II muscle fiber.”  
Search engines utilized for this search included Web of Science, Google Scholar, 
Medline, PubMed, Boise State University Albertson Library Worldcat, Science Direct, 
and ASC Publications.  
ATP-PCr Energy System 
Enzymes: The Biologic Catalysts 
Enzymes are large protein catalysts that are highly specific in function, catalyzing 
the forwards and backwards rates of chemical reactions without being altered or 
consumed during the respective reactions.34 They reduce the required activation energy 
(initial energy to start a reaction), changing the rate of the reaction without changing 
equilibrium constants and free energy.34 Their globular, three-dimensional protein 
structure determines the interaction with a specific substrate.22 This interaction takes 
place, described as a “lock-and-key mechanism” or “induced fit,” when the active site on 
the outer surface of the protein interlocks perfectly with the active site of the respective 
substrate.34,88,89 Subsequent to the formation of the enzyme-substrate complex, a new 
product with the new bonds is created after the initial splitting of the chemical bond.34 
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For all-out PA, associated energy system enzyme activity increases to about 100-times 
their resting level, especially during each step of the hydrolysis process.22 
Hydrolysis Reactions 
The hydrolysis, or “water splitting,” process catabolizes complex, organic 
molecules, with the splitting of chemical bonds initiating the decomposition process by 
adding the components of water (H2O; hydrogen atom (H
+) and a hydroxyl group (OH-)) 
to the byproducts of the reaction, as shown in the basic hydrolysis reaction equation: (AB 
+ HOH → A-H + B-OH).90 Each step of the decomposition process is accelerated by 
specific enzymes.91 During maximal-effort PA, the enzyme-mediated hydrolysis of both 
PCr and ATP are critical for maintaining adequate ATP levels and overall intramuscular 
energy homeostasis.40 
ATP: The Energy Currency 
ATP is a naturally occurring nucleotide that is found in every cell of the human 
body.8 Approximately 10% more ATP is found in type II muscle fibers than in oxidative, 
type I fibers (eg, .the vastus lateralis versus the soleus muscle).92 Its base is purine 
(adenine) and ribose (adenosine) and is linked to three negatively-charged Pi groups.
8,90 
The fact that these negatively charged Pi groups are so closely packed and repel each 
other makes ATP highly unstable.8,90 Chemically speaking, the triphosphate tail is similar 
to a tightly-bounded spring that is ready to uncoil with great energy.8,90 Thus, ATP is the 
ideal agent of energy-transfer, as it stores potential energy from ingested food molecules 
within its phosphate bonds and readily transfers this energy to other low-energy 
compounds to raise them to a greater activation level.90  
15 
 
When ATP undergoes hydrolysis and its terminal, energy-packed Pi group is 
anaerobically cleaved off, the chemical “spring” becomes relaxed, making the entire 
molecule more stable.90 Upon the release of this Pi from ATP, an abundance of free 
energy gets released (~7.3 kcal·mol-1), 𝐴𝑇𝑃 = 𝐻2𝑂 
𝐴𝑇𝑃𝑎𝑠𝑒
→     𝐴𝐷𝑃 + 𝑃𝑖 + 7.3 𝑘𝑐𝑎𝑙.
34,93 
This energy from the hydrolysis of ATP (mediated by the ATPase enzyme) powers all 
bodily functions, such as nerve transmission, tissue synthesis, and muscular action.13 In 
muscle cells, molecular motors are powered and muscle shortening is energized thanks to 
this release of free energy.60 ADP is then anaerobically converted back to ATP – 
primarily in the muscle cells’ cytosol, as PCr undergoes hydrolysis in order to maintain a 
continuous supply of ATP.22 Hence, PCr, an energy reservoir, is a critical component of 
the phosphate energy system. 
PCr: The Energy Reservoir 
ATP’s storage is limited due to its heavy weight and to increase sensitivity of the 
energy production response.29 This makes maximal-effort PA possible for only a few 
muscle-twitches, or 4-10 s, if relying primarily on ATP as an energy source.3,7 To 
maintain energy homeostasis and keep intramuscular levels of ATP stable (at 
approximately resting levels), PCr is hydrolyzed and phosphorylates the direct byproduct 
of ATP hydrolysis, ADP, within a fraction of a second to resynthesize ATP.28,78,90,94 
Phosphocreatine, also referred to as creatine phosphate, is a phosphorylated Cr molecule 
(Cr + Pi).
3,7 The enzyme-mediated (CK) hydrolysis of PCr yields a much higher free 
energy (10.3 kcal mol-1) than the ATPase-mediated hydrolysis of ATP, which is enough 
energy to power the phosphorylation of ADP to ATP.3 PCr, thereby, serves as the high-
energy P-bond reservoir.3  
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Immediate Energy via the ATP-PCr Energy System 
During maximal exercise, the rate of ATP turnover in skeletal muscle may 
increase several hundredfold.17 Despite this vast increase in ATP turnover, intramuscular 
ATP content remains relatively unchanged.17,34 This ATP hydrolysis/resynthesis balance 
is possible because ATP is resynthesized via PCr.17 The ATP-PCr energy system 
maintains four significant roles within skeletal muscle: 1) temporally buffers muscle ATP 
(to maintain ATP stores), 2) spatially buffers ATP (decrease cellular gradients of both 
ATP and ADP), 3) controls the oxidative phosphorylation process, and 4) acts as the 
primary buffer of H+ in the skeletal muscle cell.17  
Muscular fatigue has been associated with decreased PCr levels and intramuscular 
pH, resulting in the inability to continue muscular contractions.6,95-98 Muscular energy 
deficiency may not be the product of ATP shortage but may rather be due to increases in 
ADP and Pi (products of ATP hydrolysis), as it has been shown that muscle force, 
velocity, shortening, and rate of relaxation may be impaired by the increased presence of 
both ADP and Pi.
17 This suggests that muscular fatigue is more so a result of product 
inhibition than a lack of substrate availability.17 Increasing available intramuscular 
substrates through Cr supplementation has been shown to delay muscular fatigue and 
increase muscular performance by better utilizing the ADP and Pi for resynthesis of the 
high energy phosphates.26 
As ATP is used, the increase in byproducts of the high-energy phosphate 
hydrolysis, adenosine monophosphate (AMP; result of ATP utilization exceeding ATP 
regeneration) and Pi, initiate the breakdown of glucose through glycolysis without the 
need for O2.
14,17,20,99,100 Glycolysis breaks down the six-carbon glucose into two three-
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carbon pyruvates as well as liberating electrons and H+.14 Pyruvate can either continue to 
be broken down via the Kreb’s cycle if O2 is present or, if energy demand is high, be 
cleared by forming lactate.14 Ensuing PCr degradation, anaerobic glycolysis 
predominates and provides approximately 70% of the entire energy demand for near-
maximal PA lasting approximately 30-180 s.14,16,20,99 Anaerobic glycolysis (lactate end-
product) is a rapid process that yields only limited amounts of ATP.101 Considerable 
amounts of lactate can accumulate in the blood and increase more than 30-fold above 
resting levels during maximal movements utilizing large muscle groups.14,16,20,99 One’s 
muscular endurance heavily relies on this energy system and has implications for PA, 
such as maximal sprints and resistance training that lasts for approximately 30 s.14,16,20,99 
Further, this applies for activities lasting slightly longer, such as during the last few 
hundred yards of a mile run or maximal effort on a 440 m run or 100 m swim.22 
When the pyruvate end-product of glycolysis enters the Kreb’s cycle, it is a slow 
process that requires O2 and yields substantial amounts of ATP to provide almost all the 
necessary energy for PA lasting for several minutes and beyond.102,103 Taking the 
pyruvate formed in glycolysis, the Kreb’s cycle transfers electrons and H+ atoms to the 
electron transport chain (ETC).103 It is within the ETC that aerobic metabolism relies on 
O2, as it is the final electron acceptor within the respiratory chain, where it bonds with H
+ 
to form water (H2O) as ATP is formed.
103 Energy substrate availability determines one’s 
cardiovascular endurance and the ability of the aerobic system to replenish ATP, which 
has implications for endurance activities, such as long-distance walking, jogging, 
running, and swimming.22 The amount of ATP turnover during aerobic activities is very 
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high, yet this is a slow process when compared to fast glycolysis and the phosphagen 
system.17 
Creatine Supplementation: Ergogenic Benefits 
Cr is purchased over-the-counter as a dietary supplement and comes in numerous 
forms: powder, capsules, tablets, and stabilized liquid, though purity is not guaranteed as 
dietary supplements are unregulated by the Food and Drug Administration.26,104,105 In 
1994, a regulatory framework pertaining to dietary supplements in the United States was 
established by the Dietary Supplement Health and Education Act (DSHEA, 1994), which 
eliminated regulation of the supplement industry. Consequently, sales of dietary 
supplements in the US increased from $4 billion (1994) to $35 billion (2015), more than 
an eight-fold increase over a 21 y time span.39,104-107 Around the year 2000, alone, an 
estimated 2.5-thousand metric tons of Cr was consumed, which coincides with 2001 sales 
of Cr supplements ($400 million), and one can assume that as US dietary supplement 
sales have continued to increase over time, Cr sales have, too.26,41 More than 48% of male 
collegiate athletes use, or have used Cr as a supplement in preparation for their respective 
competitions; such numbers for females in this population have not been reported.41 
Among strength and power athletes (eg, Olympic lifters, powerlifters, strongman 
competitors, and recreational weightlifters), the prevalence of Cr is much greater, 
exceeding 80%.41 Further, upwards of 71% of youth and adolescent athletes report using 
dietary supplements, and 90% of those in high school who reported using dietary 
supplements reported supplementing with Cr.41,108  
CrH2O supplementation during training has been found to enhance performances 
in running (improved final, total, and best times for 300 and 1,000 m and 4 x 1,000 m 
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runs), cycle ergometry (better maintenance of pedal frequency at 4-6 s (all three bouts) 
and at the end of a 10 s bout, and increased peak-power, mean power, and total work on 
bouts 1 and 2), bench press (increased 1RM and amount of repetitions completed at 70%-
repetition maximum), isokinetic unilateral knee-extension (greater peak-torque 
production on bouts 2, 3, and 4), and the jump squat (increased peak-power production 
on all five trials), to list a few.23,43-48 
A myriad of studies, though not all, show that Cr supplementation can 
significantly enhance healthy young adults’ abilities to produce greater muscular force 
and/or power output for maximal, short-duration exercise, especially those with brief 
intervals of rest between exercise bouts, and less so for enhancing single-effort 
performances (eg, 1RM testing).26 Participants in these studies vary in athletic ability, 
ranging from untrained to high-level collegiate athletes, and the improved activities 
include short-duration, maximal cycling, repeated jumping, sprinting, swimming, and 
resistance training, to list a few.26  
Acute Cr supplementation has been found to enhance resistance training in 
multiple instances.23,47 In one study, Volek et al. split fourteen resistance trained men into 
two groups (placebo (Pl)) or Cr group), and both groups executed a jump squat protocol 
(5 sets, 10 repetitions, 30% of participants’ 1RM) and a bench press protocol (5 sets, 
failure, 10-repetition maximum). This took place on three occasions, each trial separated 
by 6 d while discontinuing resistance training. Prior to trial 1, neither group was 
supplemented, from trial 1 to trial 2 both groups ingested the Pl treatment, and between 
trial 2 and trial 3, the Cr group consumed 25 g CrH2O·d
-1 while the Pl group consumed 
the same amount of the Pl treatment. The Pl group exhibited no significant increases in 
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bench press repetitions completed from trial 2 to trial 3, while the Cr group saw 
significant increases on all five sets (p ≤ 0.05).23 The authors concluded that 1 wk of 25 
g·d-1 Cr supplementation increases muscular performances during repeated sets of jump 
squat and bench press exercises, likely due to the greater TCr pools from 
supplementation.23 
Moreover, Earnest et al. reported similar findings in their investigation of CrH2O 
supplementation among ten highly weight-trained male participants and its effects on 
anaerobic power indices, muscular strength, and body composition.47 Participants 
underwent three consecutive 30 s Wingate ergometer tests with 5 min off in between each 
Wingate trial. Peak anaerobic power was defined as the highest power achieved within a 
given 5 s work interval, while anaerobic work was denoted as the total amount of 
performed work within the 30 s work period.47 Further, the free weight bench press was 
used to assess 1RM as maximal muscular strength, followed by assessment of the number 
of repetitions achieved on the free weight bench press (70% 1RM) until fatigue, cadenced 
by a metronome (60 beats·min-1).47 Lastly, body composition was assessed using 
hydrostatic weighing techniques. Participants were either supplemented with (double-
blind) Pl (n = 4) or CrH2O (n = 4, 20 g·d
-1) and after 14 d they re-tested their Wingate 
performances and after 28 d re-tested their bench-pressing exercises and anthropometric 
measures. It was unspecified if participants resistance trained during their 
supplementation protocols. For all post-test Wingate re-trials, the Cr group saw 
significant increases in anaerobic work (13%, 18%, 18%, respectively, (p < 0.05), while 
the Pl group saw no significant increases.47 Further, several 5 s intervals over all three re-
trial Wingate periods showed significant (p < 0.05) increases (specific data not 
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reported).47 1RM bench press performance increased by 6% in the Cr group.47 Total 
lifting volume was significantly greater in the Cr group (absolute: 26%, p < 0.01; relative: 
29%, p < 0.001). No changes in body weight or fat free mass (FFM) were noted for the Pl 
group, though the Cr group saw significant increases in body weight but not FFM (body 
weight: 86.5  13.7 vs. 88.2  14.1 kg, p < 0.05; FFM: 77.6  10.8 vs. 79.2  11.6 kg, p = 
0.054).47 The authors concluded that CrH2O could be utilized as an ergogenic aid to boost 
athletic performance as it increased submaximal resistance training volume.47 
Balsom and colleagues found CrH2O supplementation to increase short-term, 
maximal cycling performance.44 Participants (n = 16; resistance trained males) underwent 
two high-intensity, intermittent exercise protocols, once before and once after the 
supplementation of either CrH2O (5 g
 CrH2O + 1 g glucose·d
-1; five times, daily, 14 d) or 
Pl (6 g·d-1 glucose; five times, daily). Participants were instructed to refrain from PA 24 h 
before each testing session but otherwise were instructed to maintain their typical daily 
PA. Each cycling protocol consisted of ten 6 s bouts of high-effort cycling at two 
different exercise intensities (130 revolutions·min-1, ~820 W; 140 revolutions·min-1 ~880 
W).44 The latter of the two intensities were meant to induce fatigue during the 10 s 
exercise bouts while the former was meant to allow for participants to execute the same 
amount of work pre and post trials. The Pl group exhibited no significant improvements 
in any of the assessed physiological measures.44 In the 140-revolution trial, there was 
significantly increased performance (+10 revolutions·min-1) towards the end (4-6 s, p < 
0.05) of each bout of exercise when the participants were supplemented with CrH2O.
44 
The authors therefore concluded that CrH2O ingestion allowed prolonged muscular 
performance at higher intensities.44 They attributed this to an enhanced PCr pool in the 
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resting state before exercise, in addition to an accelerated resynthesis of PCr during the 
recovery periods.44 Thus, Cr supplementation postpones the onset of muscular fatigue 
during repeated bouts of near-maximal exercise.44 
Sprinting performance has been shown to be enhanced after CrH2O 
supplementation by Earnest and colleagues.109 Their investigation was to determine if 
supplementation of CrH2O would enhance anaerobic, intermediate-length, treadmill 
running to exhaustion. Investigators sought to see if anaerobic capacity, and time to 
exhaustion per trial (TTEtrial), and total time to exhaustion (TTEtotal; cumulative, across all 
trials) could be enhanced with CrH2O supplementation for bouts of work lasting up to 90 
s. Eleven male participants (n = 11) received either a glucose Pl or CrH2O treatment (20 
g·d-1, 4 d and 10 g·d-1, 6 d) while maintaining their normal PA routines during the 
treatment period. They performed two treadmill runs to exhaustion at individually 
prescribed grades with 8 min of rest between runs.109 Participants executed the two 
exhaustive treadmill runs at 214 m·min-1 at either a 10, 15, or 20% grade.109 TTEtrial and 
TTEtotal were measured as a sum of both run trials. Results showed that there was a 
significant improvement for the Cr group for TTEtotal with a 5.7 s increase (p = 0.05) and 
a decrease of 2 s in the Pl condition (exhausted faster).109 TTEtotal was significantly 
enhanced in the posttest trial for the Cr group (pre-test: 176.5 ± 11.4 s; posttest: 182.2 ± 
14.6 s).109 Researchers also measured blood lactate levels, and as expected, as TTE 
increased, so too did the bioenergetic dependency on anaerobic glycolysis, and thus, the 
increased levels of blood lactate.24 They concluded that the increased TTEtotal was 
attributed to greater TTE capability for each bout and thus, Cr supplementation may 
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contribute to longer, intermediate-duration, near-maximal performances that are interval 
in nature.109 
Swimming performance has also been found by Grindstaff et al. to be enhanced 
by CrH2O supplementation.
110
 The authors had eighteen competitive swimmers, male and 
female, supplement with either CrH2O (21 g·d
-1) or Pl (maltodextrin, 21 g·d-1) for 9 d 
during their training sessions. Both before and after the supplementation protocol, 
participants executed three 100-m (long-course) freestyle sprint-swims, and three 20 s 
maximal-effort, arm ergometer sprint tests (prone), both with 60 s of rest/recovery 
between exercise bouts.110 Following CrH2O supplementation, participants in this group 
swam significantly faster than the Pl group in the 100 m swim (CrH2O: Heat 1: -0.27 ± 
0.3 s; Heat-2: -0.93 ± 0.4 s; Heat-3: -0.36 ± 0.3 s; Pl: Heat-1: 0.86 ± 0.3 s, Heat-2: -0.40 ± 
0.5 s, Heat-3: 0.02 ± 0.3 s), significantly improved heat-2 swim time, and showed a 
tendency to better their cumulative swim times for all three 100 m swims (p = 0.057).110 
As a whole, CrH2O supplemented participants decreased their swim times by -1.57 ± 0.8 
s in comparison to the Pl group which increased their swim times by 0.48 ± 0.6 s (p = 
0.057).110 As for the ergometer for the upper extremity, sprint performance was 
significantly increased for the first of the three trials and in comparison to the Pl group, 
they showed 7.8%, 5.3%, and 0.5% increases in performance, respectively, across all 
three trials.110 The authors concluded that CrH2O supplementation may enhance 
repetitive sprint-swim performance among competitive junior swimmers.110 
Again, it is important to note that not all studies have found CrH2O 
supplementation to instigate ergogenic benefits.82,111-117 It remains uncertain as to why 
there has been some discrepancies in the literature, though it has been suggested the 
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disparities may perhaps be due to: 1) placebo effects, 2) differing performance tasks used 
across studies, 3) small magnitudes of treatment effects, 4) relatively vast test-retest 
reliability error for the measurement of the given performance tasks, and 5) most likely 
because Cr supplementation is meant to increase intramuscular TCr stores, and as will be 
reviewed below, not everyone positively responds to Cr supplementation when consumed 
by itself.26 
As for the above studies that found positive performance effects associated with 
the oral supplementation with CrH2O, they shared many common variables in terms of 
methodologies. For instance, nearly all the studies mentioned had only male participants. 
This alone disregards any discrepancies that may have been prevalent had female 
participants been included in the data sets. Indeed, one study noted that women showed 
less absolute increases in lean body mass after CrH2O supplementation versus their male 
counterparts, which was attributed to their smaller muscle mass, by nature.118 This may 
also indicate that women have altered Cr uptake abilities in comparison to men, and thus, 
it is important that women be included in future Cr studies.  
Moreover, all the studies investigated near-maximal PA that was interval in 
nature. This calls for brief periods of rest/recovery between bouts of exercise, which 
allows for the ATP-PCr energy system to recover ATP levels by way of PCr 
hydrolysis.29,42,48 As the number of exercise trials increased per a given study, so too did 
the effects of the Cr treatments. While some acute performance increases occurred as 
well (eg, trial-1 on upper-extremity ergometer testing and 1RM bench press 
performance), the majority of the ergogenic benefits came from repeated bouts of 
executing a single performance task.110 
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As for the supplemental protocols, participants who were in the experimental Cr 
groups were typically supplemented with about 20-30 g CrH2O·d
-1. This dose was shown 
by Harris and colleagues to adequately increase intramuscular TCr content among most 
participants, and thus, has been used in the hundreds of Cr studies since.42 Supplemental 
protocols in the above literature ranged from acute to somewhat long-term, and all were 
associated with positive performance outcomes. This is likely because, as will be 
discussed in the following section, most Cr uptake by the body occurs within the first 
couple of supplementation days and decreases thereafter.42,85,119  
In all, overwhelmingly more studies than not have found Cr supplementation to 
have positive performance outcomes when appropriately dosed and when the selected 
exercise protocol reflects the function of the ATP-PCr energy system than not. To best 
achieve these ergogenic benefits, it is imperative that Cr uptake by the body and skeletal 
musculature be maximized, which will be reviewed in the next section. 
Creatine Monohydrate: Uptake and Retention Assessed via Urinalysis 
Inulin increases caused by the intake of simple CHO has been shown to augment 
Cr retention in skeletal muscle.81 Thus, this section is dedicated to studies not 
supplementing Cr with simple CHO. This section is dedicated to studies that investigated 
CrH2O supplementation and its ability to be absorbed by the intestines and retained by 
the body upon ingestion. 
Among the first researchers to investigate oral Cr supplementation and its ability 
to be taken up by the body by way of tracing the Cr-creatinine (Cn; sole end product of 
Cr breakdown) balance via the urine, were Chanutin and Colleagues, in 1925.85 For this 
experiment, the authors of the study also served as the participants (n = 2, males). 2 wk 
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prior to the start of the study, participants followed a Cr-free diet (no meat or fish). 
Further, participants engaged in daily, non-vigorous PA throughout the course of the 
study, with activities being varied and unspecified. This 2 wk period served as their 
control period from which they took their basal urine tests (participant 1 average daily 
outputs: Cn = 1.51 g; Cr retained = N/A; extra Cn eliminated = N/A).85 The experimental 
periods lasted for 29 (participant 1) and 44 d (participant 2), and the administered CrH2O 
doses were either 10 or 20 g·d-1. Participant 1 first supplemented with 10 g·d-1 for the 
duration of 10 d (average daily outputs (g): Cn = 6.19; Cr retained = 4.54; extra Cn 
eliminated=0.60).85 Following, this participant ingested 20 g·d-1 which lasted for 8 d 
(average daily outputs (g): Cn = 16.45; Cr retained = 4.23; extra Cn eliminated = 1.93).85 
Following, participant 1 underwent a 2 d period where was consumed 10 g·d-1 again 
(average daily outputs (g): Cn = 11.43; Cr retained = -0.21; extra Cn eliminated = 1.16), 
then a final, 2 d period where no Cr was administered (average daily outputs (g): Cn = 
3.71; Cr retained = N/A; extra Cn eliminated = 0.65).85 He followed a different protocol, 
followed a control period (average daily outputs (g): Cn = 1.61; Cr retained = N/A; extra 
Cn eliminated = N/A), followed by three, 10 d (10 g·d-1), supplemental periods (average 
daily outputs (g): Cn = 6.37; Cr retained = 4.48; extra Cn eliminated = 0.62: Period 2 
average daily outputs (g): Cn = 10.10; Cr retained = 1.35; extra Cn eliminated = 1.22: 
Period 3 average daily outputs (g): Cn=10.44; Cr retained = 0.816; extra Cn eliminated = 
1.03), a 5 d (10 g·d-1), supplemental period (average daily outputs (g): Cn = 10.06; Cr 
retained = 1.09; extra Cn eliminated = 0.93), and concluded with 2 d of no Cr 
supplementation (average daily outputs (g): Cn = 2.82; Cr retained = N/A; extra Cn 
eliminated = N/A).85 The first few d of Cr feeding allowed for very high Cr retention by 
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the body (Participant 1: d 1, 5.91 g, d 2, 5.32 g; Participant 2: d 1, 6.80 g, d 2, 6.15 g).85 
However, from these points forth, gradual decreases in the retention of Cr in the body are 
noted with coincidental increases in urinary Cn levels.85 Both participants had 
approximately 115 g of baseline intramuscular Cr content and at the end of their 
respective experimental periods, Participant 1 retained 58 g of the 270 g (assumed in the 
skeletal muscle tissue) total Cr consumed over the 29 d period, while Participant 2 
retained 38 g of the 340 g (assumed in the skeletal muscle tissue) consumed over the 44 d 
period.85 This would equate to an elevation in intramuscular Cr storage of 33% 
(Participant 1) and 50% (Participant 2).85 From these findings, the authors concluded that 
1) intestinal absorption is approximately 100% (via urinalysis), 2) Cn excretion gradually 
increases as Cr supplementation continues, 3) most of the Cr retained by the body takes 
place within 1-2 d of supplementing, and 4) approximately 90% of the ingested Cr is 
excreted in the urine with prolonged supplementation, beyond the first few days.85 
A study by Harris et al. is much more recent and sought to see if doses of orally 
supplemented CrH2O were 1) retained by the body and 2) increased intramuscular Cr 
content.1 There were 17 participants (10 males, 7 females) between the ages of 20 and 62, 
two of which were vegetarian, and all with varied fitness levels (untested). Participants 
were not instructed to change their diets nor change their daily PA. 20 g·d-1 (5 g, four 
times, daily) CrH2O was consumed by Participants 1 and 2 (4.5 d), Participants 3 and 4 (7 
d), and Participant 5 (10 d). 5 g·d-1 (6 times, daily) CrH2O was supplemented by 
Participants 6-8 (7 d) and Participants 9-12 (alternate d, 21 d). The rest of the participants 
(n = 5) underwent similar doses but were tested under exercised conditions to note any 
training effects associated with the Cr consumption and thus, will be disregarded by this 
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section of the review as it is solely focused on Cr retention by the body. Muscle biopsies, 
blood samples, and 24 h urine samples were taken from all participants, though only four 
participants had complete urine data collected. A 5 g dose of CrH2O (about that found in 
1.1 kg of raw steak) was selected based on blood sampling of participants as 7 h of 
sampling at this dose provided a high mean peak concentration of approximately 795 (± 
104) µmol·l-1 at 1 hour with a stable Cn concentration of only 70-100 µmol·l-1, as 
compared to a 1 g administered dose (plasma Cr concentration only approximately 1 
µmol·l-1).1 Though there were only four complete urine collection analyses, consistent 
even with the incomplete analyses, it revealed that the greatest uptake of Cr occurred 
during the first 2 d, regardless of dose (20-30 g Cr).1 Over the first 3 d for participants 13-
15 (5 g, 6 times a day), renal excretion of the total 30 g dose was 40%  14%, 61%  3%, 
and 68%  15%, respectively.1 Among these participants during these first 2d, the 
estimated mean Cr uptake by the muscle was approximately 17.7  3.4 g which equates 
to approximately 32% of the administered Cr dose, 20% as PCr.1 From d 2 to d 4, Cr 
uptake gradually increased another 9.1  1.6 g, approximately 50% of what was taken up 
the first 2 d.1 This differed from the previous study in that 100% of the Cr was reported to 
be digested. In all, an intramuscular Cr concentration increased by approximately 25 
mmol·kg-1 (dry muscle; DM), however, with between-subject variation rather vast (2-40 
mmol·kg-1 (DM)).1 This variation should be expected given the varied supplementation 
protocols participants were assigned to.  
Hultman and colleagues followed up the Harris et al. study in 1996 with their 
investigation of Cr retention among men.119 Thirty-one men participated in this study 
which had four different experiments (each participant assigned to only one) and lasted 
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for 2 y. No participant was considered highly trained, though all reported being at least 
somewhat physically active. Further, participants were to maintain their usual diets and to 
refrain from strenuous PA throughout each experiment. Of the four experimental groups, 
Group-4 was the only group to test for Cr excretion via the urine. Group-4 consisted of 
seven participants (age = 23 ± 1.8 y, body mass = 74.3 ± 5.4 kg).119 Each participant 
consumed 20 g of the Pl (Maxijul glucose polymer) for 5 d and 24 h urine samples were 
collected 1 and 6 d prior to the start of Pl ingestion.119 Urine collection also took place on 
Pl ingestion d 1, 3, and 5, and then on d 8, 11, 15, 22, and 25 for a 20 d period that 
followed the placebo (Pl) ingestion period. Following this period, participants then 
repeated the previously mentioned procedures, but with 20 g·d-1 of Cr rather than the Pl. 
These supplemental periods were originally planned to last 6 d each, but as previously 
found in Groups-1 and -2, intramuscular Cr retention was peaked after d-5 and started to 
decline after (d 5: 142.6 ± 2.3 mmol·kg-1 DM; d 6: 147.2 ± 4.7 mmol·kg-1 DM).119 The 
authors reported that there was a vast between-subject variation for Cn excretion among 
participants for the first 20 d of this experimental trial, though on the final day 20 they 
could obtain a post-Cr consumption average for Cn excretion (2.8 mmol·d-1 > Pl 
ingestion (p < 0.05)).119 The majority of the Cr retained by the muscle tissue took place 
during the first 2 d of Cr supplementation (~30%) as compared to only 15% on d 2-4.119 
The mean increase in intramuscular TCr across all experimental groups who ingested 20 
g·d-1over the 6 d period (high-dose, fast Cr load) was 20 mmol·kg-1 DM. Other groups 
(not mentioned earlier, no urinalysis) supplemented with only 3 g·d-1 over a 28 d period 
(a low-dose, long-duration Cr load), and while accumulation of Cr was slower, the 28 d 
result proved to show no difference in intramuscular TCr retention.119 It is important to 
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note, however, that the sample size in this study was small (n = 13) and additional studies 
are needed to draw more conclusive results. 
Enhanced uptake of Cr may help negate typical anecdotes of associated 
gastrointestinal discomfort or others, which though are uncommon, are reviewed below. 
Creatine Monohydrate: Adverse Effects 
There have been numerous reported adverse effects associated with CrH2O 
supplementation, ranging from gastrointestinal distress to muscle and cardiovascular 
issues.26 However, Terjung and colleagues state that these findings are not definitive are 
not enough to deem Cr supplementation as a health risk.26 At the same time, they state, it 
cannot be assumed that Cr supplementation is free from health risks; more research is 
needed.26 
One study by Vandebuerie and colleagues demonstrated that timing of Cr 
supplementation may be responsible for the reported associated stomach issues.68 Twelve 
male, non-vegetarian participants underwent a 2 h and 30 min endurance cycling protocol 
on their own bicycles mounted to an electromechanically-braked system. Once the 
participants cycled and achieved exhaustion at their 4 mmol lactate thresholds, they 
immediately followed with five maximal sprints for 10 s, with 2 min intervals of 
recovery. Prior to the exercise protocol, all participants were “Cr-loaded,” as they 
consumed 25 g·d-1 (5 d), and some participants were given Cr (5 g·h-1) or Pl during the 
workouts.68 Four out of six participants who consumed the Cr during the exercise 
protocol reported post-exercise “distress,” while the Pl treatment during exercise yielded 
two reports of distress.68 
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Juhn et al. and Schnirring’s respective studies reported muscle cramping, 
stiffness, and strains among some of their athlete-participants.120 Similarly, Tarnopolsky 
et al. found that among 81 participants who had neuromuscular disease, just one 
participant reported muscular cramping subsequent to supplementing with 10 g·d-1 (5 d) 
followed by 5 g·d-1 (5 d).120 When they put this participant under the same experimental 
Cr conditions, however, they did not complain of any muscle cramps the following 
session, suggesting that Cr may not have been responsible.120  
There have also been anecdotes of hypertension among those who supplement 
with Cr.26 However, Mihic and colleagues found via double-blind procedures that short-
term Cr supplementation (20 g·d-1, 5 d) among young male and female participants had 
no effects on mean, systolic, or diastolic blood pressures.66 Peeters et al. found in a 
similar study that the same supplemental Cr protocol yielded no blood pressure effects 
over a longer duration of time (6 wk, 20 g·d-1 (3 d), 10 g·d-1 maintenance).67 Two more 
studies found that blood pressure was not affected among participants with congestive 
heart failure who supplemented with Cr (20 g·d-1, 5 d and 20 g·d-1, 10 d).121,122 
Lastly, Cr supplementation has been scrutinized by claims that it unfavorably 
alters renal functioning because its consumption increases urinary output of Cr and Cn 
and would therefore be expected to increase Cn concentrations in the plasma.26 Short-
duration (20 g·d-1, 5 d) supplementation of Cr has been found to have no effects on 
glomerular filtration rate.65,123 Moreover, athletes supplementing with Cr for up to 5 y 
had no effect on renal functioning.50  
There have been numerous anecdotes associated with the consumption of large 
quantities of CrH2O. As discussed in the next session, this has been attributed to the lack 
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of intestinal absorption of CrH2O through the intestinal cells.
69,76,87 Nevertheless, these 
anecdotes are typically single reports, and when in some cases, the affected participant is 
re-tested under the same Cr conditions, the report of distress does not reoccur. However, 
because of these perceived issues, companies have strived to come up with alternative 
forms of commercially available Cr that can be better taken up by the body, reduce these 
anecdotal reports of ill-effects, and still provide the ergogenic benefits found with the 
supplementation of CrH2O. CrHCl is among the latest of these new forms, and shows 
promise in solubility and intestinal uptake abilities.  
Creatine HCl: Solubility and Intestinal Uptake 
Nutrients can make it through the epithelia of the intestinal tract through 
numerous mechanisms, including active transport, facilitated transport, diffusion, or 
paracellular pathways.124 Because Cr shares similar structural characteristics to simple 
amino acids it may enter systemic circulation through peptide transporters, amino acid 
transporters, or specialized transporters (eg, taurine), or possibly even through the 
paracellular route.124,125 Karlsson and colleagues reported that Cr has a molecular weight 
of 131 g·mol-1, a net positive charge, and an approximate partition coefficient of -2.7, and 
thus, should bypass the intestinal epithelia through paracellular pathways.126 However, 
Dash et al. found CrH2O to have very poor ability to bypass the intestinal epithelia.
124 
This is likely because the aqueous solubility of CrH2O has been found to be only 
approximately 16.6 ± 0.3 mg·mL-1.127 Aqueous solubility of CrHCl was found to be 38-
times greater than that of CrH2O.
87 
CrHCl was brought to the market as a dietary supplement around 2009 as an 
alternative form of supplemental Cr, more acidic than CrH2O, that is supposed to be 
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much more soluble in liquid and consequently, better absorbed by the intestines.76 To 
make CrHCl, the manufacturer mixes CrH2O with acetyl chloride and ethanol is then 
added as a solvent.76 This solution precipitates a granular form of HCl salt of Cr after the 
solution is heated between approximately 24°C and 50°C.76 Lastly, the solution is 
reduced to ambient atmospheric temperature and pressure where the CrHCl granules are 
collected and packaged for commercial use and consumption by humans or livestock as a 
dietary supplement, in a solid, oral-dosage form, such as capsules or tablets.2  
Gufford and colleagues investigated the aqueous solubility ability of CrHCl and 
other commercially available Cr salts in comparison to that of CrH2O.
87 The purpose of 
the study was to identify a water soluble Cr salt that would have increased solubility and 
bioavailability, a lower needed oral dose, and a decrease in side effects in comparison to 
CrH2O. Each of the six salts underwent nuclear magnetic resonance, elemental analysis, 
and melting-point determination, followed by high performance liquid chromatography 
(HPLC). From there, determination of saturation solubility of each salt took place in 
deionized water by slowly adding it to 5 mL of solvent in glass bottles which were settled 
in a shaking water-glass (25° C).87 Following, 2 mL aliquots were extracted and 
centrifuged (11,000 rpm) for 5 min.87 HPLC was then used to determine Cr 
concentrations. All salts were found to be significantly more soluble than CrH2O, with 
CrHCl producing the most significant increase (CrHCl: 709 ± 7; CrH2O: 17.1 ± 0.4).
87 
The authors proposed that a contributing factor is likely due to the fact all of the saturated 
salt solutions were in highly acidic states (unbuffered water; pH 0.3-3.1) as compared to 
the CrH2O solution (pH 8.6).
87 In biological fluid or neutral pH, Cr is in its least-soluble, 
electrically-neutral state due to its 7.4 isoelectric point.87  
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In another study, Gufford and colleagues investigated the permeability of CrHCl 
across the human Caco-2 epithelial cell monolayers.69 Permeability of both CrH2O and 
CrHCl were investigated using the cell-line (epithelium of human intestine) from a 
human carcinoma of the colon (Caco-2).69 The epithelial cells were seeded into 
specialized, 24 mm diameter, polycarbonate membrane inserts at 60,000 cells·cm2.69 
These cells were kept in a 5% carbon dioxide environment for approximately 21 d and 
supplemented with 10% fetal bovine serum, from which point, merged monolayers were 
reached.69 1.5 mL of simulated intestinal fluid in addition to 10 mM of CrHCl replaced 
the apical compartment of the monolayers after a 30 min period of incubation.69 The 
highest permeability in the Caco-2 monolayers was noted for CrHCl, as it was 
approximately 15-times greater than that of CrH2O (CrH2O: 0.12 ± 0.004 cm/s; CrHCl: 
4.3 ± 0.4 cm·s-1 (p < 0.05)).69  
Per these studies, it is apparent that CrHCl is indeed a much more soluble form of 
Cr in aqueous solution in comparison to CrH2O. Further, while CrHCl showed promise 
bypassing intestinal cells in vitro, TCr uptake by the body upon supplementing with it has 
yet to be quantified in a human model. Thus, the study at hand will be among the first to 
do so.  
CrHCl and Resistance Training 
Research investigating CrHCl supplementation and its effects on resistance 
training is lacking. To the author’s knowledge, only three studies to date have considered 
CrHCl as an ergogenic aid. 
The first study compared strength and body composition effects of a high CrHCl 
(5 g∙d-1) group, a low CrHCl group (1.5 g∙d-1), a CrH2O group (5 g∙d-1), and a Pl group 
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over a 4 wk period.75 Participants (n = 30; both sexes) were randomly divided into one of 
the four groups and underwent a given treatment while adhering to a prescribed 4 wk 
resistance training protocol. 1RM bench press and leg press were assessed both pre- and 
post-experiment as well as body-composition (skin fold). 1RM leg press was significantly 
increased (p < 0.05) in all groups while 1RM bench press was only significantly 
increased in the low CrHCl group (p = 0.003).75 Between group differences were not 
found. Both CrHCl groups resulted in significantly decreased FM (high: p = 0.034; low: 
p = 0.005) while FFM was significantly increased only in the high CrHCl group.75 It was 
concluded that both CrHCl and CrH2O promote gains in strength but only CrHCl 
promotes significant changes in body composition with differences in doses, which 
contradicts other research showing that CrH2O can positively influence body composition 
(eg, increase fat free mass, decrease fat mass).75 However, it is important to note that 
participants in this study were asked to refrain from any form of resistance training 4 wk 
prior to the start of the study, which may have had an impact on strength and body 
composition results.  
Another study by Reuland investigated training effects associated with a single 
dose of CrHCl supplementation (0.033 g·kg-1 bodyweight, 30 min before testing) and 
differences across genders.128 This study investigated pre- and post-total training volume 
(TTV) on five repeated sets of the barbell bench press and the incline lying leg press 
exercises with 75 s rest between each set. Lab visits were separated by 48 h (paperwork, 
1RM testing, control trial, and experimental trial) and participants were asked to refrain 
from exercise during these periods. Results for the leg press showed that women in the Cr 
and Pl groups all significantly increased TTV from the control to the experimental trial (p 
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= 0.004, p = 0.02, respectively).128 Men in the Cr and Pl groups also significantly 
increased leg press TTV (p = 0.03, p = 0.003, respectively).128 However, women in the Cr 
group had significantly higher score differences from the control to the experimental 
trials than their male counterparts (p = 0.01).128 Women’s TTV for the bench press 
showed no significant differences from pre- to post-intervention in the experimental or 
control group (p = 0.2, p = 0.21) and the same held true for men (p = 0.12 p = 0.68).128 
The authors concluded that the efficacy of CrHCl on resistance training remains unclear. 
Lastly, a study by Packer and colleagues investigated the acute effects of CrHCl 
supplementation over a 6 d period on 1RM performance on the barbell bench press, 
barbell deadlift, and CMJ among trained powerlifters.129 Participants (n = 9) were spread 
unevenly into three groups (CrHCl (n = 4): two doses at 0.750 mg·d-1; CrH2O (n = 3): 
two doses at 5 g·d-1; Pl (n = 2)).129 Participants were instructed not to resistance train or 
perform any anaerobic-style PA during the 6 d intervention period. No statistically 
significant changes were found in 1RM on any of the three performance measures from 
pre- to post-treatment (p > 0.05).129 Percent-changes for all three performance tasks for 
the CrHCl, CrH2O and Pl groups, respectively, were calculated (barbell back squat: 
2.44%, 1.54%, and 10.33%; deadlift: 1.4%, 2.21%, and 6.67%; CMJ: 2.04%, 3.61%, and 
-2.15%) and resulted in the conclusion that neither form of Cr as a dietary supplement is 
effective at augmenting 1RM on these three tasks over a 6 d supplemental period.129 
Results contrary to the previous studies were likely produced due to a very small sample 
size and because participants were instructed not to exercise during the 6 d Cr 
intervention period, which is counterintuitive due to the fact that exercised skeletal 
muscle tissue better retains Cr as shown by Harris and colleagues and once a muscle’s Cr 
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stores are full supplemented Cr is simply excreted in the urine.129 Moreover, 1RM 
performance does not truly mimic the ATP-PCr energy system where an influx of 
intramuscular Cr and PCr would be useful for ATP and PCr resynthesis during longer 
periods of near-maximal effort PA; likely, the ATP stores in the muscle prior to the 1RM 
attempts were being used as the sole energy source. Thus, Cr supplementation should not 
have been expected to increase performances on the respective 1RMs. 
Closing 
It has been established that the oral supplementation of CrH2O can enhance whole 
body and intramuscular levels of TCr, even more so when taken in conjunction with an 
insulin-stimulating companion. Because of this increase of intramuscular TCr, namely 
PCr, ATP can be resynthesized for longer durations of short-duration, maximal-intensity 
PA, especially when interval in nature with recovery-time in between exercise bouts to 
allow for further synthesis of ATP.  
However, there have been many anecdotal reports of study participants who 
supplemented with high doses of CrH2O (20-30 g) who complained about issues, such as 
gastrointestinal distress and muscle cramps, with the former of the two being attributed to 
CrH2O’s lack of ability to bypass the intestinal cells due to its low solubility in aqueous 
solution. Thus, another form of Cr (CrHCl) was introduced to the market in 2009 as a 
form of Cr that is more soluble in aqueous solution and bypasses the intestinal epithelial 
cells at a much higher rate with the purpose of providing consumers with the ergogenic 
benefits of CrH2Owithout the reported ill-effects reported by those who supplement with 
it. However, there are only three studies to date looking at the ergogenic benefits 
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associated with its consumption. Thus, the study at hand will be one of the first to 
investigate this.  
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CHAPTER THREE: METHODS 
Participants 
Sixteen healthy, resistance trained males between the ages of 18 and 34 y were 
recruited to participate in this study. Inclusion in the study required participants to have at 
least 1 y of current, consistent (minimum of 3 d·wk-1) resistance training experience, 
which was verbally verified by the PI prior to the start of the study. Exclusion criteria, 
which was also verbally assessed prior to the start of the study, excluded participants who 
were not between the ages of 18 and 34 y, had less than 1 y of current and consistent 
resistance training experience, used anabolic steroids, were vegans or vegetarians, 
diabetic, and/or were unwilling to cease the use of their current dietary supplement 
regimens.  
Participation in this study was completely voluntary and required a signed, written 
informed consent (APPENDIX A) approved by the BSU Institutional Review Board 
(IRB #103-MED17-003). The revised, 2017 version of the Physical Activity Readiness 
Questionnaire (PAR-Q; APPENDIX B) was distributed to all participants to ensure that 
they had no previous or current health conditions that would prevent them from being 
able to participate in this in the study. All screening information and collected data was 
handled with complete confidentiality. Only the PI had access to the participants’ 
screening documents locked in a designated cabinet within BSU’s Human Performance 
Laboratory (HPL). Collected data was accessed only by the PI. All participant 
information was kept electronically on a secured, BSU password-protected computer. 
40 
 
Further, each participants’ information was kept private and was stored using assigned 
IDs created by the PI of this study. The participant ID codes were kept in a separate 
location from the participant data. 
Procedures 
A pre-post experimental design was followed, as the same group of participants were 
tested twice on the same variables before and after the 1 wk treatment period. 
The Cr hydrochloride (CrHCl) supplement (NutraBio Creatine HCl; NutraBio 
Labs, Middlesex, NJ) was administered in a 1 wk supply (28 g) to each participant, in 2 g 
doses (powdered form). Participants were instructed to take two, 2 g doses daily, 30 min 
pre-, and immediately following their respective daily resistance training workouts. On 
days when participants did not resistance train, they were instructed to consume a 4 g 
dose in the morning upon waking. To minimize any potential differences in rates of 
intestinal Cr absorption, all participants were instructed to mix the powder in identical 
volumes (8 oz) of cold water and were asked to consume the mixture within a 5 min 
period from the end of mixing, starting from their first sip.78  
Two wks prior to the start of the treatment period, participants agreed to cease 
their current use of dietary supplements, which served both as a Cr washout (allowing 
intramuscular TCr levels to return to pre-supplemented levels) and control period.40 
Furthermore, participants agreed to refrain from consuming alcohol and engaging in any 
form of strenuous exercise 24 h before each testing protocol.78 
During visit 1, participants completed all paperwork and completed their maximal 
countermovement vertical jump (CMJ) height and 1 repetition maximum (1RM) on the 
bench press. Participants were then asked to recall their typical daily dietary intakes and 
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were asked to maintain similar caloric intakes throughout the course of the study (eg, make 
no major dietary changes, such as vast amounts of fast foods).  
Participants were also asked to maintain their current resistance training splits and 
continue to resistance train a minimum of 3 d·wk-1. All participants reported resistance 
training during the treatment period (per their usual routines) at least 3 d·wk-1, per study 
requirements. Of the fifteen participants, about half (n = 8) reported resistance training 4 
d·wk-1 while the remaining participants (n = 7) reported resistance training 5 d·wk-1 during 
the 7 d treatment period. All participants reported engaging in some form of a periodized, 
split-body training routine where each muscle major muscle group was only trained 1 d·wk-
1. No participant reported engaging in PA that was outside of their normal training routines.  
Pre- and post-intervention body measures were taken on visits 2 and 3 in the BSU 
HPL (height (cm): standard anthropometry stadiometer; body weight (BW; kg) and body 
composition: whole body densitometry via air displacement (Bod Pod; COSMED USA, 
Concord, CA) for fat free mass (FFM; kg) and fat mass (FM; kg), followed by the 
respective upper and lower body muscular performance assessments. Completion of visit 
2 took approximately 45 min to complete and initiated the 1 wk treatment period, as 
participants were distributed their 1 wk portions of the CrHCl treatment. Visit 3 was 
identical to visit 2 as participants repeated the performance and body composition 
assessments described above.  
The study protocol is displayed below (Table 3.1): 
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Table 3.1 Study Protocol by Week 
Time (wk) Activity Data 
0 Recruitment None 
0-2 No supplements (Cr wash-out) 
Visit 1 (1 h): 
Pre-screening/Introduction 
1RM bench press testing 
Maximal CMJ testing 
Protocol familiarization 
Assess “typical” daily diet intake 
 
1RM bench press 
Maximal vertical jump height 
Typical daily diet intake 
2 Visit 2 (45 min): 
Body measures (height, weight, body 
composition) 
Pre-treatment bench press test 
Pre-treatment lower body jump test 
Distribute CrHCl supplement  
Major dietary changes (if 
any)? 
Other supplement 
consumption? 
Body measures 
Bench press repetitions 
Number of jumps completed 
2-3 Daily supplement intake (pre-and 
post-workout) 
 
None  
3 Visit 3 (45 min): 
Body measures (height, weight, body 
composition) 
Post-treatment bench press test 
Post-treatment lower body jump test 
Major dietary changes (if 
any)? 
Other supplement 
Consumption? 
Body measures 
Bench press repetitions 
Number of jumps completed 
 
Measures 
Purity of the CrHCl Product 
CrHCl product samples were tested and analyzed for purity using an Agilent 1100 
Series High-Performance Liquid Chromatography (HPLC) Value System machine 
(Agilent Technologies, Waldbronn, Germany).130 The Agilent 1100 HPLC machine 
allows for the separation, identification, and quantification of all components of a given 
mixture, with efficient mixing and pulse-free delivery of solvents in order to provide fast 
and accurate analytical results of a given sample.130 10 mg of CrHCl was placed in 10 mL 
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of Nanopure Water, which yielded a concentration of 6.7 mM. Solvents used in the 
HPLC included ammonium formate (aqueous) and acetonitrile (organic). Sample run 
time in the HPLC machine lasted 10 m, and progressed in this fashion: 
 0-3 min: Solution is 70% ammonium formate/30% acetonitrile; 
 3-8 min: solution is 30% ammonium formate/70% acetonitrile; 
 8-10 min: solution is 70% ammonium formate/30% acetonitrile. 
1RM Bench Press 
1RM on the bench press was initially estimated using the Epley Formula:  
1RM = [1 + (0.0333 x repetitions completed)] x weight lifted.131 
Participants estimated a weight for which they could perform ten repetitions on 
the barbell bench press. This weight was multiplied by 1.33 (per the Epley Formula), 
which yielded an approximate 1RM and a starting point for testing.131 Testing began with 
a progressive barbell bench press warmup, starting with 3-5 repetitions at a very light 
weight (50% of established, estimated 1RM), resting for 2 min, completing 2-4 
repetitions at 70% of the estimated 1RM, resting for 4 min, completing 1-2 repetitions at 
80-85% of the estimated 1RM, resting for 5 min, followed by testing the determined 
estimated 1RM weight. If the participant successfully completed the first 1RM attempt, 
they were instructed to rest for 4 min, then make another attempt after adding either 5-10 
or 10-20 lbs, depending on the perceived difficulty of the previously completed 1RM, as 
has been found to be effective by Hoeger and colleagues for testing a true 1RM.132 This 
was continued until a true 1RM was established. The PI served as a spotter on all lifts to 
ensure participant safety while performing the barbell bench press, where proper form 
entailed feet maintaining contact with the floor and hips and head kept in contact with the 
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bench. If participants broke proper form at any point during a 1RM attempt, the PI racked 
the weight and ceased any further testing, and used the previous successfully completed 
1RM attempt in the data set.  
Maximal CMJ Height 
Maximal CMJ height was established using a commercially-available, vertical 
jump measuring device (Vertec; Sports Import Inc., Columbus, OH). The participants’ 
maximum standing reach heights (cm) were first be measured by the PI. Following, 
participants were guided through a warmup by performing 5 min of low-intensity cycling 
(60 revolutions·min-1; 1.5 kp) on a stationary cycle ergometer (Monark Ergomedic 828 E; 
Monark Exercise AB, Vansbro, Sweden). Following, a brief dynamic warmup took place 
which consisted of ten BW squats and five CMJ performed at 50% maximal intensity. 
Then, three trials of the maximal CMJ were completed, with 1 min of rest between each 
trial. Participants initiated the jump with both feet on the ground and descended into a 
countermovement before jumping vertically and swiping the Vertec measurement device 
at the highest possible point with the middle finger of the dominant hand, and then landed 
safely with flat feet and their knees slightly bent. Each jump height was recorded to the 
nearest 0.5”. Participants were allowed three maximal CMJ attempts. If a participant 
showed progression in jump height on each consecutive attempt, they were allowed more 
attempts until they failed to bypass the previous attempt. Maximal CMJ heights were 
calculated by subtracting the respective jump heights by the participants’ maximum 
standing reach heights (cm).  
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Anthropometric Measures 
To measure body height and weight, participants removed their shoes and only 
wore their shorts or under garments. Body heights were recorded using a stadiometer (Seca 
213 Portable Stadiometer; Seca, Chino, CA). BW, FFM, and FM were measured using a 
Bod Pod as described by Antonio and colleagues in a similar study.133 Both pre- and post-
treatment body measures were assessed in this fashion.  
Repeated Bench Press 
Repetitions completed per set and total training volume (TTV; sets x repetitions) 
on three sets the submaximal (70% of participants’ 1RM) barbell bench press were assessed 
before and after the 1 wk treatment period. Participants performed the barbell bench press 
exercise (three sets, maximal repetitions) at 70% of their previously determined 1RM, with 
2 min of rest and recovery between each set. The bench press warmups for visits 2 and 3 
were identical to that of visit 1 with the progressing percentages adjusted for the 70% 
submaximal weight. A metronome was utilized (60 beats·min-1) to control repetition tempo 
and to ensure all participants performed the exercise in the same fashion on all trials. 
Participants performed the exercise until complete muscle failure or until proper form 
(previously described) was broken, as determined by the PI. This was repeated until all 
three sets were complete. The PI served as the spotter on all lifts to ensure participant safety 
while performing the barbell bench press. 
Repeated CMJ 
Repetitions completed per set and TTV were assessed on three sets of the repeated, 
submaximal (85% of participants’ maximal vertical jump height) CMJ using the Vertec 
device before and after the 1 wk treatment period. Using previously determined maximal 
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CMJ height, participants completed as many consecutive submaximal CMJs as possible at 
85% of their maximal CMJ height. The warmup for this test was identical to that of the 
maximal CMJ test during visit 1, described above. The Vertec device was set to a height 
where the top horizontal measuring-stick was at 85% of the participants’ maximal CMJ 
heights. The participants were instructed to only slightly touch the Vertec horizontal 
measuring sticks on each successful submaximal jump attempt. Each jump was 
interspersed by 3 s (recorded by the PI) upon landing from the previous jump to allow 
proper reset of participants’ original jumping position and for the PI to quickly reset the 
moved horizontal measuring stick to its set position, if necessary.134 This was timed using 
a standard hand held digital stopwatch (Ultrak 495 Digital Stopwatch; CEI; Gardena, Ca). 
The PI was stationed on a latter placed next to the Vertec device to ensure participants 
successfully completed each submaximal CMJ and to allow for easy reset of the horizontal 
measuring stick after each attempt, if necessary. This continued until the participant could 
no longer jump at the desired height; the test was terminated after one unsuccessful 
repeated CMJ attempt. The number of successfully completed jumps at this height was 
recorded. Each set was separated by 2 min of rest/recovery. This took place for three trials 
before and after the 1 wk treatment period.  
Data Analysis 
Statistical analyses utilized the IBM Statistical Package for the Social Sciences 
(SPSS; IBM, Armonk, New York) software. Descriptive statistics (means and standard 
deviations) were calculated for age, height, BW, FFM, FM, 1RM bench press and 
maximal CMJ height. A series of one-way, repeated-measures ANOVAs were used to 
find any significant changes in body composition, bench press repetitions and number of 
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submaximal CMJs from pre- to post-treatment on a per-set and TTV basis. A significance 
level was set at p < 0.05.  
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CHAPTER FOUR: RESULTS 
Sixteen participants were initially recruited for this investigation. One participant 
dropped out due to personal health issues. Fifteen healthy, resistance trained males 
completed the study, whose baseline characteristics are listed in Table 4.1.  
Table 4.1 Participant Baseline Characteristics (n = 15). 
 Minimum Maximum Mean SD 
Age (yr) 20 27 22.8 2.0 
Height (cm) 168.0 191.0 178.5 5.8 
Body Weight (kg) 70.1 105.4 81.6 9.9 
1RMa Bench Press (kg) 65.9 255.0 120.2 42.4 
Max.b Vertical Jump Height (cm) 51.2 87.6 70.1 9.8 
a One-repetition maximum 
b Maximum vertical jump height 
Dietary Supplement and Nutrition Intake 
At the end of visits 2 and 3 participants were asked to recall their dietary intakes 
for any significant caloric changes and other dietary supplement intakes (if any). No 
participant reported changes in dietary intake at any point during the study. Every 
participant reported consuming meat daily, and all reported consuming a balanced diet 
with most of their caloric intakes coming from CHO, followed by protein, then dietary 
fats. All participants reported adhering to the request to cease the consumption of alcohol 
24 h prior to all testing sessions. 
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All participants adhered to the study guidelines and refrained from using any 
dietary supplements other than the CrHCl treatment during the study (eg, whey protein 
and caffeine). Of the fifteen participants, all but one reported no use of any dietary 
supplements prior to the start of the study. These participants bypassed the 2 wk Cr 
washout period and began their visit 1s upon their earliest convenience. The one 
participant who reported using a pre-workout dietary supplement (with Cr and other 
nutrients) reported adhering to the 2 wk Cr washout phase before reporting to the 
laboratory for visit 1. All fifteen participants reported adhering to the mixing and 
consumption protocols to ensure consistent absorption across participants. Further, all 
participants reported using the entirety of the distributed 1 wk supply of the CrHCl 
treatment and maintained proper consumption of the treatment during the periworkout 
period on training days and during the morning on rest-days, per study requirements. No 
participant reported stomach issues upon ingestion of the treatment.  
CrHCl Purity 
HPLC analysis revealed the CrHCl product to be 100% pure. Over a 10 min 
sample run time, there was a retention time of approximately 2 min and the absorption of 
the analyte was approximately 320 milli absorbance units (mAu) (Figure 4.1). Product 
purity of 100% assured that 1) participants were consuming a safe and pure product 
without any unknown substances and 2) any reported treatment effects, or lack of, could 
attributed to the CrHCl treatment with greater confidence.  
Repeated Bench Press 
There was a significant main effect of time on bench press performance score, 
indicating that from pre- to post-intervention, participants’ bench press performances 
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improved across all three sets (Figure 4.1: F (1, 14) = 106.4, p < 0.005,  = 0.88). 
Further, a significant main effect for set on bench press performance was found (F (2, 28) 
= 268.3, p < 0.005,  = 0.95). Post-hoc Bonferroni analysis indicated that participants 
performed significantly better at later sets compared to earlier sets (eg, Set 3 > Set 2 > Set 
1, p < 0.005). A significant interaction between time and set on bench press was found (F 
(2, 28) = 4.15, p = 0.026,  = 0.23), which indicates relatively larger improvement in 
bench press from pre- to post-intervention in Set 1 (Cohen’s d = 0.71) and Set 3 (d = 
0.65), but smaller improvement for Set 2 (d = 0.39). This suggests that from pre- to post- 
intervention, fatigue was better overcome when participants’ upper-body muscles were 
unfatigued (Set 1) and at the end of the assessment, when their muscles were highly 
fatigued (Set 3). Bench press data are presented in Table 4.2.  
 
Note: p < 0.005 for all sets. 
Figure 4.1 Effect for Time: Repeated Bench Press (Repetitions) 
 
2
2
2
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Table 4.2 Participant Repeated Bench Press Characteristics (repetitions). 
 Pre-Intervention Post-Intervention 
Mean SD Mean SD 
Set 
1 
13.6 2.6 15.6* 3.0 
Set 
2 
6.6 2.3 7.5* 2.2 
Set 
3 
4.2 1.8 5.5* 2.2 
* p < 0.005 
Repeated CMJ 
There was a significant effect for time on CMJ performance score, such that from 
pre- to post-intervention, participants’ CMJ performances increased on all three sets 
(Figure 4.2: F (1, 14) = 55.61, p < 0.005,  = 0.80). Additionally, a significant main 
effect for set was found (F (2, 28) = 27.5, p < 0.005,  = 0.66). Post-hoc Bonferroni 
results signified that participants performed significantly better at later sets compared to 
earlier sets (eg, Set 3 > Set 2 > Set 1, p < 0.005). No significant interaction effect (F (2, 
28) = 0.96, p > 0.05,  = 0.06) was observed between time and set on the CMJ test, 
indicating that there were no significant improvements in CMJ from pre- to post-
intervention on any set (Set 1, d = 0.41; Set 2, d = 0.59; Set 3, d = 0.63). Data for the 
CMJ test are presented in Table 4.3. 
2
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Note: p < 0.005 for all sets. 
Figure 4.2 Effect for Time: Repeated CMJ (Repetitions) 
 
Table 4.3 Participant Repeated CMJ Characteristics (repetitions). 
 Pre-Intervention Post-Intervention 
Mean SD Mean SD 
Set 
1 
14.7 7.9 18.1* 8.3 
Set 
2 
11.6 5.8 15.5* 7.2 
Set 
3 
8.6 4.7 11.7* 5.0 
* p < 0.005 
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Body Measures 
There were no statistically significant changes in FFM (F (1, 14) = 3.06, p > 0.05, 
= 0.179) or FM (F (1, 14) = 0.423, p > 0.05, = 0.029) from pre- to post-treatment. 
Notably, however, there was a significant increase in BW from pre- to post-treatment (F 
(1, 14) = 6.00, p < 0.05,  = 0.30). Data for all body composition outcomes are 
presented in Table 4.4.  
Table 4.4 Participant Body Composition Characteristics (kg). 
 Pre-Intervention Post-Intervention 
Mean SD Mean SD 
BWa 
81.6 9.9 82.2* 9.6 
FFMb 
70.4 8.0 71.3 7.9 
FMc 11.3 3.1 10.9 3.8 
*p < 0.05 
a Body weight 
b Fat-free mass 
c Fat mass 
2 2
2
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CHAPTER FIVE: DISCUSSION 
Consuming CrH2O as a dietary supplement with the intent of enhancing anaerobic 
muscular performance and body composition (eg, increasing FFM, decreasing FM) has 
shown consistent efficacy in the literature. Companies are producing alternative forms of 
Cr, such as CrHCl, to offset the various anecdotal reports of biological distress associated 
with consuming the relatively large amounts of CrH2O required to reap the ergogenic 
benefits. However, literature examining CrHCl in a human model is lacking and its 
efficacy remains unclear in augmenting muscular performance and favorable adaptations 
in body composition. Identifying the effect of oral CrHCl supplementation on 
submaximal, intermittent bouts of resistance exercise will help establish its effectiveness 
as a dietary supplement and will allow consumers to make educated decisions when 
purchasing Cr products.  
In this study, measurements of completed repetitions on three sets of the barbell 
bench press and CMJ exercises were taken pre- and post-intervention in human 
participants. The results from the present study suggest that consuming 4 g CrHCl·d-1 in 
the periworkout period for 7 d is beneficial for increasing repetitions on repeated bouts of 
submaximal bench press and CMJ exercises when taken to complete muscle failure. This 
supports the hypothesis that 7 d of CrHCl supplementation (4 g·d-1) taken in the 
periworkout period will increase repetitions on three repeated sets of the barbell bench 
press and CMJ exercises. Though participants were all previously well-versed in both 
performance assessments prior to the start of the study and practiced both tests during 
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their Visit 1, it is important to acknowledge that learning effects or self-competition 
(trying to improve upon their baseline performances) may have contributed to these 
results. However, previous research examining repeated bouts of high intensity resistance 
exercise noted that learning effects from pre- to post-intervention are unlikely due to 
participants’ previous resistance training experience ( 1 y).135 Thus, the lack of a control 
group in the present study likely was not an issue. Moreover, similar findings have been 
reported in the literature examining CrH2O supplementation and its effects on repeated 
bouts of submaximal exercise.23,136 
A similar experiment investigated CrH2O supplementation for 7 d (25 g·d
-1) and 
its effects on five intermittent bouts of submaximal bench press (10 RM, failure) and 
jump squat exercises (30% 1RM barbell back squat, ten repetitions), with each trial 
separated by 2 min rest.23 Peak power output (W) on all five sets of the jump squats and 
total training volume (TTV) on all five sets of the bench press were significantly 
enhanced (p < 0.05), with the highest numbers recorded on the first sets and progressively 
decreasing on the four subsequent sets.23 Though the experimental design (maximal 
repetitions at 85% maximal CMJ height) and performance measure (maximal repetitions) 
for the repeated jumps test was different in the present study, similar results were 
produced. The significant effect for time on repeated CMJ performance suggested a 
significant increase in completed repetitions across all three sets from pre- to post-
intervention. Thus, participants in the current study were also able to prolong the 
production of lower body peak power output and maintain their submaximal CMJ 
performances during post-intervention testing, as performance increased concurrently 
with increases in body mass. Bench press results in the present study were also similar, in 
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that repetitions across sets were significantly enhanced from pre- to post-intervention. 
These results are likely attributed to more energy being derived from the enhanced 
phosphagen pool from the CrHCl treatment and a delayed transition into anaerobic 
glycolysis.44,46 
An investigation of acute CrH2O supplementation (20 g·d
-1, 5 d) on maximal 
repeated vertical jumping performance (45 s) reported significant (p < 0.05) enhancement 
in average jump height during the first 15 s (+ 7%) and 30 s (+ 12%), but not the final 15 
s, when the energy-shift was likely being made to anaerobic glycolysis and aerobic 
metabolism.136 These results are similar to those in the present study where participants 
were likely able to produce greater muscular power as time and fatigue increased and 
continue reaching their 85% maximal CMJ heights, as evidenced in the post-intervention 
CMJ performance results, described above. In slightly longer CrH2O interventions (14 d), 
three pre-/post-trials of the 30 s maximal Wingate test were significantly enhanced 
(+13%, +18%, +18%, respectively, p < 0.05) as quantified by total anaerobic work and 
for submaximal bench press testing (28 d; 70% 1RM, one trial) for maximal repetitions 
(+26%, p < 0.05).47 Similarly, the present study saw upper and lower body increases in 
total anaerobic work capacity as seen by the increases in repetitions for the submaximal 
repeated CMJ and bench press exercises following the Cr treatment. However, the study 
at hand shows that similar performance results can be achieved in only 7 d.  
Results associating CrH2O supplementation with prolonged muscular power 
production during submaximal, intermittent bouts of exercise may be attributed to an 
increased quantity of PCr resynthesis due to increases in intramuscular Cr during the 
prescribed rest/recovery periods, and ultimately, an elevated PCr pool at the initiation of 
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each successive bout of exercise.25 To maintain elevated power output during repeated 
maximal jumps, for example, requires constant ATP recycling via PCr hydrolysis at the 
myosin cross-bridge sites to maintain ideal myosin-head cycling with active sites located 
on the actin filament and elevated intramuscular PCr would enhance this.23,60 Brief 
periods of rest/recovery (eg, 2-5 min) allow for rapid PCr resynthesis which can be 
approximately 95% restored in 3-4 min.9 Thus, repeated, intermittent performances on 
the submaximal bench press and CMJ exercises can be expected to be improved by Cr 
supplementation as demonstrated in this study. 
Total intramuscular TCr seems to play a role in performance.19,25 Individuals with 
lower basal TCr concentrations (eg, non-supplemented individuals or vegetarians) 
experience more benefit as they tend to have a greater relative and absolute increase in 
TCr pools upon supplementation (+ ~20%) and the extent to which intramuscular TCr 
pools increase is related to the enhancement in muscular performance.30 With TCr 
retention so important for reaping ergogenic benefits from Cr supplementation, those 
consuming Cr would ideally increase their intramuscular TCr pools from the average 
120-140 mmol·kg-1 (DM) to the known upper limit of 150-155 mmol·kg-1 (DM).60  
However, publications examining CrHCl supplementation and retention have yet 
to be conducted in a human model, making it unclear as to the appropriate dose and 
timing needed to properly increase intramuscular TCr levels. This may explain why there 
have been disparate results in the literature across the few available CrHCl training 
studies. Possible discrepancies in the literature may be attributed to factors, such as 
varied dosing of the CrHCl treatments, length of the treatment periods, or testing 
protocols not fully utilizing the phosphagen energy system.26,30,60 One study that 
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examined the 4 wk effects of a high dose (5 g·d-1) or low dose (1.5 g·d-1) of CrHCl versus 
5 g·d-1 CrH2O and a Pl group reported increases in 1RM leg press in all groups but only 
1RM bench press in the low CrHCl group.75 Participants in this study were asked to 
refrain from all PA 4 wk prior to the start of the study which may have played a role in 
the reported strength increases. Another study had participants consume a single dose 
(0.033 g·kg-1) of CrHCl, 30 min prior to pre- and post-testing on five repeated sets of the 
bench press and leg press with 75 s rest between each set.128 It was found that TTV for 
men and women in the leg press significantly improved (men: + 12.9%, p = 0.03; 
women; + 32.7%, p = 0.004) for all groups including the Pl while TTV on the bench 
press showed no significant improvements in any group.128 This is likely due to only a 
single dose of CrHCl not being enough to maximize TCr stores in the muscle cells. In 
addition, participants were asked to refrain from exercise between the control and 
experimental trials although exercised muscle tissue better takes up and stores circulating 
Cr than unexercised muscle tissue. It is also possible that the 75 s rest periods were not 
sufficient enough for PCr resynthesis between exercise bouts.60 A third investigation 
looked at 6 d CrHCl supplementation (750 mg·d-1, twice daily) on 1RM performances on 
the bench press, back squat, and deadlift exercises and found no significant changes post-
treatment.129 Because 1RM attempts do not rely on phosphate sources other than already 
available ATP, increased intramuscular TCr through supplementation without resistance-
training for only 6 d would not likely instigate the necessary training effects necessary to 
augment significant gains in maximal muscular strength.60  
In an attempt to build on the aforementioned literature and eliminate 
discrepancies in results, the present study took each potential flaw in the aforesaid 
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research designs and addressed them accordingly. First, participants were asked to 
maintain their usual resistance training regimens (minimum 3 d·wk-1) before and 
throughout the Cr intervention period. This would help eliminate performance 
improvements being attributed to unexercised muscle tissue undergoing a resistance 
training and Cr intervention, as opposed to previously resistance trained muscle tissue 
continuing to resistance train while undergoing a Cr intervention. Further, a single dose 
of Cr taken 30 min prior to a maximal, weight-bearing performance assessment would 
not likely elevate intramuscular TCr levels enough to provide a difference in 
performance, especially when asked to refrain from resistance training leading up to the 
assessment. Thus, the present study had participants resistance train while supplementing 
with 4 g of CrHCl in the periworkout period around their respective resistance training 
workouts, over a 7 d span, which would likely better increase their skeletal muscle TCr 
stores and improve their intermittent, submaximal resistance training performances. 
Additionally, rest periods under 2 min, as discussed previously, are not sufficient enough 
to allow sufficient PCr resynthesis following a trial of maximal-effort PA.9 Therefore, the 
study at hand utilized 2 min rest periods between testing trials which would allow 
sufficient PCr resynthesis by utilizing ATP from oxidative metabolism and the anaerobic 
metabolism of hexose monophosphates (accumulated during intense exercise) to pyruvate 
before the successive testing trials.9 Lastly, studies testing pre- and post-1RM after an 
acute Cr treatment period should not expect to see significant improvements, as such lifts 
tend to use energy from readily available phosphates, namely ATP.30 Thus, the current 
study designed a performance protocol that utilized exercises that rely primarily on the 
ATP-PCr energy system and would more likely benefit from Cr supplementation. 
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Regardless, there are still some limitations in the design of this study, which will be 
discussed at the end of this section.  
In this investigation, FFM and FM saw no statistically significant changes from 
pre- to post-intervention (p > 0.05 for both). However, BW was significantly increased 
from pre- to post-intervention (F (1, 14) = 6.00, p < 0.05,  = 0.30). Mean bodyweight 
in the present study increased approximately 0.6 kg. Many CrH2O studies with acute 
treatment periods (6-14 d) have reported similar increases in body mass, ranging from 
0.5-2.0 kg.23,25,44,47,61,80,81,114,137 As indicated by decreases in urinary volume upon Cr 
supplementation, this may be mostly attributed to increased retention of body water.119 
This may be due to the fact that increased Cr content in the muscle cell increases osmotic 
pressure, which moves H2O into the cell and retains it, leading to weight gain.
70 It is 
important to note that no participants in the present study reported any biologic distress 
during the intervention period. Further, consuming CrH2O in the periworkout period has 
been found to increase FFM while decreasing FM, which may help further influence 
changes in body composition.133 Thus, the study at hand had participants split their daily 
CrHCl doses pre- and post-workout on days where they resistance trained.  
These results suggest that supplementing with 4 g of CrHCl over a 7 d period may 
benefit those who seek to improve muscular performances during intermittent, 
submaximal PAs and avoid possible biologic distress associated with CrH2O 
supplementation at such high doses. Thus, supplementing with CrH2O is approximately 
$0.29 cheaper per day to supplement with compared to CrHCl. This may have more 
specific implications for those other than just healthy men who resistance train. For 
instance, the National Football League Scouting Combine utilizes a 225 lb (~102.3 kg) 
2
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bench press test (maximal repetitions to fatigue) to assess upper body muscular strength 
and endurance. A potential recruit may be 1 wk out from the Scouting Combine and still 
need to improve on the number of repetitions he can perform during the submaximal 
bench press test. With this knowledge, his trainer may have him supplement with 4 g of 
CrHCl·d-1 around his workouts, for 7 d, with the intent of increasing his intramuscular 
TCr stores, and thus utilizing more phosphate energy sources before transitioning to 
anaerobic glycolysis. This would allow for more completed repetitions on the 
submaximal bench press test. 
Additionally, players who participate in sports that require repeated bouts of 
maximal vertical jumping, such as volleyball, may benefit from these findings. The 
ability to sustain near-maximal CMJ height may allow players to compete at higher levels 
through the duration a given match. Coaches can therefore utilize these results and have 
their players practice and resistance train their lower extremities while supplementing 
with 4 g of CrHCl·d-1 during the week before a match. With an increased TCr pool in the 
lower extremities, the athletes should expect to maintain submaximal CMJ performances 
for longer periods of time during a given match. 
Regardless of the sport, to maximize the benefits of CrHCl supplementation, the 
PA one wishes to improve upon should stress the phosphagen energy system and should 
have brief periods of rest/recovery between bouts, ranging from 2-5 min. This has proven 
to be an effective alternative to supplementing with high doses of CrH2O. 
However, a 500 g bottle of CrH2O has a retail cost of $14.99 (USD; 20 g·d
-1 = 
$0.60·d-1) while a 135 g bottle of CrHCl sells at retail for approximately $30.00 (USD; 4 
g·d-1 = $0.89·d-1).86  
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Limitations and Future Research 
There were some limitations in the present study. One major limitation of the 
current study was the small sample size. Data from 15 participants is not enough to 
generalize the results to larger populations outside of a cohort of healthy, resistance 
trained men. Additionally, the brief, 7 d treatment period may not have been sufficient for 
some individuals as they may respond slower to Cr supplementation (delayed uptake of 
intramuscular TCr) or may not respond at all (Cr treatment has no influence on 
intramuscular TCr content) and this was not assessed in this study.26 Further, muscle 
biopsy techniques or tracer methodologies were not used to quantify intramuscular TCr 
content pre- and post-intervention, so it cannot be concluded that the improvements in 
performance were a direct result of the Cr treatment. Moreover, although all participants 
reported consuming their normal diets throughout the intervention, only general diet 
information was collected and specific caloric intakes, especially from meat, were not 
tracked throughout the intervention. Differences in energy intake, especially from Cr-
dense meat, could have further increased participants’ intramuscular TCr stores and 
influenced performance results. Lastly, this was an open trial as participants were not 
blinded to the CrHCl treatment, which may be a cause for bias.  
Follow up studies should longitudinally investigate CrHCl supplementation in 
resistance trained men and women with a greater sample size and investigate the long-
term effects on performance and body composition. Further, CrHCl supplementation 
among older populations of both sexes should be examined for TCr retention, body 
composition and anaerobic performance outcomes to further assess its effects on other 
populations. Moreover, basal and post-intervention intramuscular TCr content should be 
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measured via biopsy techniques or tracer methodologies to measure the retention effects 
of CrHCl in comparison to CrH2O, and assess the correlation between retention level and 
performance changes. Caloric intake, especially meat intake, should be controlled to 
ensure the consumption of meat products remains consistent throughout the treatment 
period. Lastly, participants should be blinded to the treatment and the CrHCl group 
should be compared against a CrH2O group and a Pl group to avoid potential bias.  
Conclusion 
In conclusion, supplementation with 4 g of CrHCl for 7 d in healthy, resistance-
trained men significantly increases the number of repetitions performed during 
intermittent bouts of submaximal bench press and CMJ exercises and body weight.  
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Informed Consent Form 
Study Title: Oral Creatine Hydrochloride Supplementation: Acute Effects on 
Submaximal, Intermittent Bouts of Bench Press and Vertical Jump Exercises 
Principal Investigator:  
DJ McDonough 
Co-Investigator:  
Dr. Shawn Simonson 
Sponsor: N/A 
This consent form will give you the information you will need to understand why 
this research study is being done and why you are being invited to participate. It will also 
describe what you will need to do to participate as well as any known risks, 
inconveniences or discomforts that you may have while participating. We encourage you 
to ask questions at any time. If you decide to participate, you will be asked to sign this 
form and it will be a record of your agreement to participate. You will be given a copy of 
this form to keep. 
 PURPOSE AND BACKGROUND 
The purpose of this research is to examine the effects of 1-week of oral creatine 
hydrochloride supplementation on three sets of the free weight barbell bench press 
exercise at 70% of your 1 repetition maximum and repeated submaximal 
countermovement vertical jump exercise at 85% of your maximal vertical jump height. 
This will provide us with further information about the potential athletic-enhancing 
effects of supplementing with a newer form of creatine for 1-week. To participate in this 
study, you must be a non-vegetarian male between the ages of 18 and 34 years, in good 
physical health (no diagnosed cardiovascular, pulmonary, metabolic, joint, or chronic 
disease), and have a minimum of 1-year of resistance-training experience and currently 
resistance-train a minimum of 3-times per week. Further, you must agree to cease the use 
of all dietary supplements for 3-weeks, during the study.  
 PROCEDURES 
You will be asked to come to the Boise State University Kinesiology Annex 
Building on 3 occasions. 
Visit 1 – Paperwork, body composition measurement, and familiarization 
trial (2 hrs) 
During your first visit, you will complete all paperwork, have your body height 
and composition (% body fat, fat free mass, and fat mass) measured, and complete a 
practice trial of the protocol procedures that will take pace during visits 2 and 3. Body 
composition will be measured with a system that measures the amount of air your body 
takes up within a chamber. This is an egg-shaped structure that uses changes in air 
pressure and your body size to determine your total body composition breakdown.  
You will be asked to wear a tight-fitting bathing suit or lycra/spandex shorts with 
a swim cap covering the hair to reduce air blockage. You will enter the system and sit for 
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approximately one minute. You will breathe regularly and remain motionless during the 
testing procedure. A large window is centered in the front of the system so you may see 
out into the laboratory and may communicate with an investigator if necessary. An 
emergency release button is located inside the system should you need to terminate the 
test for any reason. 
Next, you will be asked to provide a dietary recall of your typical daily food 
consumption. This will be used to assess any major dietary changes that may take place 
during the study. Following, you will be asked to complete practice trials on the free 
weight bench press and repeated countermovement vertical jumping exercises. This will 
be identical in nature to the exercise sessions completed during visits 2 and 3. Following, 
you will be asked to complete testing for your 1 repetition maximum on the free weight 
bench press exercise, followed by maximal countermovement vertical jump height testing 
using the Vertec, which is a vertically adjustable height-measuring device. Before 
leaving, you will be distributed a 1-week (28 grams (fourteen 2 gram packets): 7-days, 4 
grams per day) supply of the creatine hydrochloride treatment. You will be asked to take 
one 1-serving packet (2 grams) of the creatine supplement 30 minutes before your 
resistance training workout and one 1-serving packet (2 grams) immediately after your 
resistance training workout. On days where you do not resistance train (rest-days), you 
will be asked to take two 2-serving packets (4 grams) in the morning at the same time on 
every rest-day. Each time you consume the creatine supplement, you will be asked to take 
it in 300mL of semi-cold water, and consume within 5-minutes after mixing.  
Visit 2 and 3 – Experimental trials (1.5 hrs) 
During visits 2 and 3 you will assess all body measures in the same fashion as 
visit 1. Following, you will complete a progressive bench press warmup until working up 
to your 70% 1 repetition maximum bench press, established during visit 1. Following, 
you will complete three trials of the bench press at this weight identical to the practice 
trials during visit 1. Following, you will complete a low-intensity, 5-minute warmup on 
the stationary cycle ergometer before completing 3 trials of the repeated vertical jumping 
test, identical to the practice trial during visit 1. 
 RISKS 
The potential risks that may occur with participating in this study include those 
associated with any exercise. These include muscle/joint soreness, lightheadedness, 
nausea, and in rare instances, fainting, and heart attack. However, the possibility of 
serious events happening in people who have no previous history of heart disease is low. 
The Human Performance Laboratory has a planned response to any emergency procedure 
and all testing personnel are CPR certified. Consuming high doses of creatine has been 
associated with some anecdotes of gastrointestinal distress. However, the creatine 
hydrochloride supplement you will be asked to take will be consumed at a fraction of the 
dose as typically used in research studies. 
BENEFITS 
There will be no direct benefit to you from participating in this study. However, the 
results of this study may provide information as to which form of commercially available 
creatine, sold as a dietary supplement, is superior for acute ergogenic benefits.  
EXTENT OF CONFIDENTIALITY 
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Reasonable efforts will be made to keep the personal information in your research 
record private and confidential. Any identifiable information obtained in connection with 
this study will remain confidential and will be disclosed only with your permission or as 
required by law. The members of the research team and the Boise State University Office 
of Research Compliance (ORC) may access the data. The ORC monitors research studies 
to protect the rights and welfare of research participants. 
Your name will not be used in any written reports or publications which result 
from this research. Data will be kept for three years (per federal regulations) after the 
study is complete and then destroyed.  
 PAYMENT 
You will not be paid for your participation in this study. You will receive 1 free, 
unopened bottle of creatine upon full completion of the study.  
 PARTICIPATION IS VOLUNTARY 
You do not have to be in this study if you do not want to. You may also refuse to 
answer any questions you do not want to answer. If you volunteer to be in this study, you 
may withdraw from it at any time without consequences of any kind or loss of benefits to 
which you are otherwise entitled. 
 QUESTIONS 
If you have any questions or concerns about your participation in this study, you 
may contact the Principal Investigator, Daniel McDonough: 650-580-6253 or 
djmcdonough@u.boisestate.edu. 
If you have questions about your rights as a research participant, you may contact 
the Boise State University Institutional Review Board (IRB), which is concerned with the 
protection of volunteers in research projects. You may reach the board office between 
8:00 AM and 5:00 PM, Monday through Friday, by calling (208) 426-5401 or by writing: 
Institutional Review Board, Office of Research Compliance, Boise State University, 1910 
University Dr., Boise, ID 83725-1138.  
DOCUMENTATION OF CONSENT 
I have read this form and decided that I will participate in the project described 
above. Its general purposes, the particulars of involvement and possible risks have been 
explained to my satisfaction. I understand I can withdraw at any time. 
 
 
 
 
    
Signature of Person Obtaining Consent  Date 
 
 
 
      
Printed Name of Study 
Participant 
 Signature of Study 
Participant 
 Date 
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APPENDIX C 
Institutional Review Board Protocol
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This research was conducted under approval from the Institutional Review Board 
at Boise State University, protocol #103-MED-003. 
